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SUMMARY :   6 
A deficiency of pejvakin, a protein of unknown function, causes a strikingly 7 
heterogeneous form of deafness. Pejvakin-deficient (Pjvk-/-) mice also exhibited variable 8 
phenotypes. Correlation between their hearing thresholds and the number of pups per 9 
cage suggested a possible harmful effect of pup vocalizations. Direct sound or electrical 10 
stimulation showed that the cochlear sensory hair cells and auditory pathway neurons 11 
of Pjvk-/- mice and patients were exceptionally vulnerable to sound. Pjvk-/- cochleas 12 
displayed features of marked oxidative stress and impaired anti-oxidant defenses. We 13 
showed that pejvakin is associated with peroxisomes, and is required for the oxidative 14 
stress-induced proliferation of these organelles. In Pjvk-/- hair cells, peroxisomes 15 
displayed structural abnormalities after the onset of hearing. Noise-exposure of wild-16 
type mice rapidly upregulated Pjvk cochlear transcription, and triggered peroxisome 17 
proliferation in hair cells and primary auditory neurons. Our results reveal that the 18 
anti-oxidant activity of peroxisomes protects the auditory system against noise-induced 19 
damage.  20 
 21 
HIGHLIGHTS 22 
 23 
Pejvakin-deficient mice and humans are hypervulnerable to sound exposure. 24 
 25 
Oxidative stress induces a pejvakin-dependent proliferation of peroxisomes. 26 
Peroxisome proliferation contributes to the physiological response to sound exposure. 27 
Pjvk gene transfer can rescue Pjvk-/- mice from auditory dysfunction.  28 
  29 
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INTRODUCTION 1 
Mutations of PJVK, which encodes pejvakin, a protein of unknown function present 2 
only in vertebrates, cause the DFNB59 recessive form of sensorineural hearing impairment. 3 
In the first patients described (Delmaghani et al., 2006), the impairment was restricted to 4 
neurons of the auditory pathway, as demonstrated by the combination of abnormal auditory 5 
brainstem responses (ABRs) with decreased wave amplitudes and increased inter-wave 6 
latencies (Starr & Rance, 2015). ABRs monitor the electrical response of auditory pathways 7 
to brief sound stimuli, from the primary auditory neurons synapsing with the sensory cells of 8 
the cochlea, the inner hair cells (IHCs), to the colliculus in the midbrain (Møller & Jannetta, 9 
1983). However, some DFNB59 patients were found to have a cochlear dysfunction, as 10 
shown by an absence of the otoacoustic emissions (OAEs) that are produced by the outer 11 
hair cells (OHCs), frequency-tuned cells endowed with electromotility that mechanically 12 
amplify the sound-stimulation of neighboring IHCs (Ashmore, 2008). These patients had 13 
truncating mutations of PJVK, whereas the previously identified patients had missense 14 
mutations (p.T54I or p.R183W) (Ebermann et al., 2007; Schwander et al., 2007; Borck et 15 
al., 2011). However, the identification of patients also carrying the p.R183W missense 16 
mutation but lacking OAEs (Collin et al., 2007) refuted any straightforward connection 17 
between the nature of the PJVK mutation and the hearing phenotype. The severity of 18 
deafness in DFNB59 patients varies from moderate to profound, and may even be 19 
progressive in some patients, suggesting that extrinsic factors may influence the hearing 20 
phenotype. 21 
We investigated the role of pejvakin, with the aim of determining the origin of the 22 
phenotypic variability of the DFNB59 form of deafness. Our study of Pjvk knockout mouse 23 
models and of patients revealed an unprecedented hypervulnerability of auditory hair cells 24 
and neurons to sound-exposure, accounting for phenotypic variability. We found that 25 
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pejvakin is a peroxisome-associated protein involved in the oxidative stress-induced 1 
proliferation of this organelle. Pejvakin-deficient mice revealed the key role of peroxisomes 2 
in the redox homeostasis of the auditory system and in the protection against noise-induced 3 
hearing loss. 4 
 5 
RESULTS 6 
Heterogeneity in the hearing sensitivity of Pjvk-/- mice 7 
We generated pejvakin-null (Pjvk-/-) mice carrying a deletion of Pjvk exon 2 resulting 8 
in a frameshift at codon position 71 (p.Gly71fs*9) (Figure S1 and see Extended 9 
Experimental Procedures). ABRs were recorded on postnatal day 30 (P30), to assess hearing 10 
sensitivity. ABR thresholds at 10 kHz ranged from 35 to 110 dB SPL in these mice (n = 48), 11 
but never exceeded 30 dB SPL in their Pjvk+/+ littermates (n = 26) (Figure 1A). This broad 12 
range of hearing sensitivity in Pjvk-/- mice, from near-normal hearing to almost complete 13 
deafness, extended across the whole frequency spectrum. The thresholds of distortion-14 
product OAEs (DPOAEs) at 10 kHz (i.e. the minimum stimulus required for DPOAEs 15 
production by OHCs) also fell within an abnormally large range of values, from 30 to 75 dB 16 
SPL, in 28 Pjvk-/- mice, corresponding to OHC dysfunction, and DPOAEs were undetectable 17 
in another 20 Pjvk-/- mice, indicating a complete OHC defect (Figure 1B). The absence of 18 
pejvakin in mice thus results in a puzzlingly large degree of hearing phenotype variability.  19 
 20 
Hypervulnerability to the natural acoustic environment in Pjvk-/- mice 21 
We investigated the variability of Pjvk-/- auditory phenotypes, by first determining 22 
the ABR thresholds of Pjvk-/- littermates from different crosses. Large differences were 23 
observed between crosses, with much lesser differences between the Pjvk-/- littermates of 24 
individual crosses. Litters with larger numbers of pups (6 to 12) had higher ABR thresholds, 25 
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suggesting that the natural acoustic environment, with the calls of larger numbers of pups, 1 
might be deleterious in Pjvk-/- mice. Pups are vocally very active from birth to about P20. 2 
We manipulated the level of exposure to pup calls by randomly splitting large litters of Pjvk-3 
/- pups into groups of 2, 4, 6 and 10 pups per cage, with foster mothers, before the onset of 4 
hearing (P10). The ABR thresholds at P21 were significantly correlated with the number of 5 
pups raised together (p < 0.001, r2 = 0.51, i.e. 51% of the variation in ABR threshold is 6 
determined by the number of pups per cage) (Figure 1C).  7 
We then evaluated the effect on hearing of a controlled sound-stimulation, by 8 
presenting 1000 tone bursts at 10 kHz, 105 dB SPL (2-ms plateau stimulations separated by 9 
60-ms intervals of silence), energetically equivalent to a 3-minute stay in the natural 10 
environment of a 12-pup litter, while monitoring the ABRs during sound-exposure. These 11 
conditions are referred to hereafter as "controlled sound-exposure". We probed the effect of 12 
sound exposure by ABR tests which, limited to 50 repetitions of tone bursts, did not 13 
influence the hearing thresholds of Pjvk-/- mice. In a sample of P30 Pjvk-/- mice with initial 14 
ABR threshold elevation below 35 dB SPL, controlled sound-exposure affected ABR 15 
thresholds in the 12-20 kHz frequency interval (corresponding to the cochlear zones where 16 
hair-cell stimulation was strongest (Cody & Johnstone, 1981)), with an immediate increase 17 
of 21.7 ± 10.3 dB (n = 8; p < 0.001), not observed in Pjvk+/+ mice (2.2 ± 2.4 dB, n = 12; p = 18 
0.3) (Figure 1D). Pjvk-/- mice transferred to a silent environment after exposure displayed a 19 
further increase of 33.7 ± 16.0 dB (n = 8) two days after exposure. The threshold shift 20 
decreased to 23.7 ± 18.0 dB at seven days, and disappeared entirely by 14 days. When 21 
exposed mice were returned to the box with their littermates, their ABR continued to 22 
increase, at a rate of 15 dB per week. Pejvakin deficiency thus results in particularly high 23 
levels of vulnerability to low levels of acoustic energy, and the increase in ABR thresholds 24 
is reversible but only slowly and in a quiet environment.  25 
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 1 
Hair cells and auditory pathway neurons are affected by pejvakin deficiency  2 
To identify the cellular targets of the pejvakin deficiency, we specifically probed the 3 
function of auditory hair cells and neurons in Pjvk-/-, hair cell-conditional Pjvk knockout 4 
(Pjvkfl/flMyo15-cre-/-), and Pjvk+/+ mice, at the age of three weeks, before and after controlled 5 
sound-exposure or controlled electrical simulation. The responses of the IHCs to sound-6 
induced vibrations amplified by OHCs trigger action potentials in the distal part of primary 7 
auditory neurons, at the origin of ABR wave-I. In Pjvkfl/flMyo15-cre+/- mice, which lack 8 
pejvakin only in the hair cells, ABR wave-I amplitude and latency at 105 dB SPL 9 
specifically probed IHC function, because IHC responses to such loud sounds are 10 
independent of OHC activity (Robles & Ruggero, 2001). The larger wave-I latency (1.58 ms 11 
in Pjvkfl/flMyo15-cre+/- mice (n = 20) vs. 1.32 ms in Pjvk+/+ littermates (n = 30); p < 0.001) 12 
and lower wave-I amplitude (37% of the amplitude in Pjvk+/+ littermates; p < 0.001) 13 
suggested a dysfunction of the IHCs in the absence of pejvakin. Controlled sound exposure 14 
induced further decreases in ABR wave-I amplitude in Pjvk-/- and Pjvkfl/flMyo15-cre+/- mice 15 
(48% and 55% of pre-exposure amplitude, respectively) with respect to Pjvk+/+ mice (108%; 16 
p < 0.001 for both comparisons) (Figure 2A), demonstrating that IHCs lacking pejvakin are 17 
hypervulnerable to sound. As shown above, OHCs are also affected by the pejvakin 18 
deficiency. Controlled sound-exposure triggered a mean increase in the DPOAE threshold of 19 
17.1 ± 6.7 dB in the 12 to 20 kHz frequency interval (p < 0.0001) in Pjvk-/- mice with 20 
persistent DPOAEs (n = 8), but had no effect on the DPOAEs of Pjvk+/+ mice (n = 9; p = 21 
0.51) (Figure 2B). OHCs lacking pejvakin are, thus, also hypervulnerable to sound.  22 
We investigated the effect of the absence of pejvakin on the auditory pathway by 23 
comparing electrically evoked brainstem responses (EEBR) in Pjvk-/- and Pjvkfl/flMyo15-24 
cre+/- mice (see Extended Experimental Procedures). The amplitudes of the most distinctive 25 
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EEBR waves, E II and E IV, did not differ between the two types of mice (e.g., for wave E 1 
IV: 2.6 ± 1.8 µV in Pjvk-/- mice (n = 18) and 2.2 ± 1.2 µV in Pjvkfl/flMyo15-cre+/- mice (n = 2 
11); t-test, p = 0.13). However, following controlled electrical exposure at 200 impulses / s 3 
for 1 minute, as opposed to electric-impulse stimulation with 16 impulses / s for 10 s for pre- 4 
and post-exposure EEBR tests, the amplitudes of the E II and E IV EEBR waves were 41% 5 
and 47% smaller, respectively, for at least 3 minutes, in Pjvk-/- mice (n = 5; p = 0.02 and p = 6 
0.01, respectively), but were unaffected in Pjvkfl/flMyo15-cre+/- mice (n = 10) (Figures 2D, 7 
2G-2I). The E II-E IV interwave interval was 0.41 ms longer in Pjvk-/- mice (n = 5) than in 8 
Pjvkfl/flMyo15-cre+/- mice (n = 10; t-test; p = 0.003) and controlled electrical exposure 9 
extended this interval by a further 0.15 ms in Pjvk-/- mice only (paired t-test, p = 0.001) 10 
(Figures 2H and 2I). Likewise, the latency interval between ABR wave I and wave IV (the 11 
counterpart of wave E IV) was abnormal in one third of the Pjvk-/- mice tested (n = 12) 12 
(Figures 2C and 2E), and was further increased by controlled sound-exposure in all Pjvk-/- 13 
mice (n = 12 ears with an ABR threshold < 95 dB SPL, a mean increase of 0.16 ms relative 14 
to the pre-exposure value; paired t-test, p < 0.001). By contrast, it remained normal in 15 
Pjvkfl/flMyo15-cre+/- mice (n = 10 ears; p = 0.73) (Figures 2C and 2F).  We conclude that the 16 
absence of pejvakin affects the propagation of action potentials in the auditory pathway after 17 
both controlled electrical and sound-exposure, as demonstrated by the reduced amplitude of 18 
the E II wave and the increased E II-E IV and ABR I-IV interwave intervals in Pjvk-/- mice.        19 
We tested whether these abnormalities were of neuronal or glial origin by performing 20 
a rescue experiment in Pjvk-/- mice, using adeno-associated virus 8 (AAV8) vector-mediated 21 
transfer of the murine pejvakin cDNA. AAV8 injected into the cochlea transduces the 22 
primary auditory neurons and neurons of the cochlear nucleus (Figure S2A). All Pjvk-/- mice 23 
(n = 7) injected on P3 and tested on P21 had normal ABR interwave I-IV latencies (Figure 24 
2J), and their EEBR wave-E IV amplitude was insensitive to controlled electrical 25 
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stimulation (1.91 ± 0.97 µV before and 1.87 µV ± 1.07 after stimulation; paired t-test, p = 1 
0.59) (Figures 2K and 2L). The absence of pejvakin thus renders auditory pathway neurons 2 
hypervulnerable to exposure to mild, short stimuli.  3 
 4 
Hypervulnerability to sound in DFNB59 patients  5 
We then investigated whether the hearing of DFNB59 patients was also 6 
hypervulnerable to sound-exposure. We tested five patients carrying the p.T54I mutation 7 
from the series reported by Delmaghani et al. (2006). Transient-evoked OAEs (TEOAEs) 8 
assessing OHC function over a broad range of frequencies were detected for all ears, despite 9 
the severe hearing impairment (hearing threshold increasing from 66 dB HL at 250 Hz to 84 10 
dB at 8 kHz). Following minimal exposure to impulse stimuli (clicks at 99 dB nHL), ABR 11 
waves were clearly identified in response to 250 clicks. When exposure was prolonged to 12 
1000 clicks (the standard procedure), wave V, the equivalent of mouse ABR-wave IV, which 13 
was initially conspicuous, displayed a marked decrease in amplitude (to 39 ± 30% of its 14 
initial amplitude) and an increase in latency (of 0.30 ± 0.15 ms) (Figure 3A, 3C, and 3D). In 15 
parallel, the I-V interwave interval increased by 0.30 ± 0.15 ms. Wave-V amplitude and 16 
latency recovered fully after 10 minutes of silence (Figure 3B). In control patients with 17 
sensorineural hearing impairment of cochlear origin matched for ABR thresholds, similar 18 
sound stimulation did not affect ABR wave-V amplitude (105 ± 14% of the initial amplitude 19 
after exposure; n = 13 patients) or latency (-0.02 ± 0.07 ms change after exposure) (Figures 20 
3C and 3D). Exposure of the DFNB59 patients to 1000 clicks also affected TEOAEs (6.1 ± 21 
5.2 dB nHL decrease in amplitude; paired t-test, p = 0.02). Therefore, as in pejvakin-22 
deficient mice, the cochlear and neuronal responses of DFNB59 patients were affected by 23 
exposure to low-energy sound.  24 
 25 
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Redox status abnormalities and ROS-induced cell damage in the cochlea of Pjvk-/- mice 1 
 We investigated the impact of pejvakin deficiency on cochlear structure in Pjvk-/- mice, 2 
by light microscopy on semithin sections, and electron microscopy. On P15 and P21, both 3 
OHCs and IHCs were normal in number and shape. Their hair bundles (the 4 
mechanoreceptive structures responding to sound), the ribbon synapses of the IHCs and their 5 
primary auditory neurons were unmodified (data not shown). On P30, we observed the loss 6 
of a few OHCs (16 %), restricted to the basal region of the cochlea (tuned to high-frequency 7 
sounds). From P30 onwards, numerous OHCs and cochlear ganglion neurons disappeared 8 
and the sensory epithelium (organ of Corti) progressively degenerated (Figure S3A). 9 
We investigated possible changes in gene expression in the organ of Corti (which 10 
includes not only hair cells, but also various types of supporting cells) in young Pjvk-/- mice, 11 
by microarray studies on P15 (see Extended Experimental Procedures). Eighteen genes had 12 
expression levels at least 1.5-fold higher or lower in Pjvk-/- mice than in Pjvk+/+ mice. 13 
Marked differences were observed for four genes involved in the redox balance — CypA, 14 
Gpx2, c-Dct, and Mpv17 — encoding cyclophilin A, glutathione peroxidase 2, c-15 
dopachrome tautomerase, and Mpv17, respectively (Table S1). All these genes were 16 
downregulated in Pjvk-/- mice, a result confirmed by quantitative RT-PCR (Figure S4A), and 17 
all encode antioxidant proteins, suggesting an impairment of antioxidant defenses in Pjvk-/- 18 
mice (Table S1).  19 
We thus assessed anti-oxidant defenses in the cochlea of P21 Pjvk-/- mice, by 20 
determining the ratio of reduced to oxidized glutathione (GSH:GSSG). The GSSG content 21 
was about three times larger than in Pjvk+/+ mice, whereas the GSH content was 23% 22 
smaller, resulting in a GSH:GSSG ratio in Pjvk-/- cochleas lower than that in Pjvk+/+ cochleas 23 
by a factor of 3.4 (Figure 4A). No significant differences in GSSG and GSH levels or in the 24 
GSH:GSSG ratio in the liver were detected between Pjvk+/+ and Pjvk-/- mice (data not 25 
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shown). Increase in GSSG level and decrease in the GSH:GSSG ratio are markers of the 1 
cochlear oxidative stress accompanying the pejvakin deficit. 2 
 We assessed lipid peroxidation by reactive oxygen species (ROS) in Pjvk-/- mice, by 3 
immunofluorescence-based detection of the by-product 4-hydroxy-2-nonenal (4-HNE). 4 
Strong immunoreactivity was observed in P60 Pjvk-/- hair cells and cochlear ganglion 5 
neurons (Figure S3B). Quantification of lipid peroxidation in microdissected organs of Corti 6 
from P30 Pjvk-/- and Pjvk+/+ mice, showed a moderate (16%) but statistically significant 7 
increase of the malondialdehyde content in the absence of pejvakin (2.15 ± 0.14 µM in Pjvk-8 
/- vs. 1.84 ± 0.11 µM in Pjvk+/+ mice, means ± SD; t-test, p = 0.04). Thus, pejvakin 9 
deficiency led to impaired antioxidant defenses in the cochlea, resulting in ROS-induced cell 10 
damage. 11 
We then studied electrophysiological features of IHCs and OHCs in the mature 12 
cochlea of P19-P21 Pjvk-/- mice. In IHCs, the number of synaptic ribbons, Ca2+ currents, and 13 
synaptic exocytosis (assessed by monitoring the increase of the cell capacitance following 14 
cell depolarization) were unaffected (Figure S7A). As IHC functions also depend on 15 
potassium ion channels known to be affected by ROS, we investigated whether Pjvk-/- mice 16 
display the main K+ currents found in mature IHCs, specifically IK,f, which plays a major 17 
part in IHC repolarization and is involved in the high temporal precision of action potentials 18 
in postsynaptic nerve fibers, IK,s, and IK,n (Oliver et al., 2006). In Pjvk-/-mice, IK,f flowing 19 
through the large conductance voltage- and Ca2+-activated potassium (BK) channels, a 20 
known target of ROS (Tang et al., 2004), was detected in only 4 out of 11 Pjvk-/- IHCs, and 21 
the mean number of spots immunolabeled for the BK α-subunit per IHC was much lower in 22 
Pjvk-/- mice (5.0 ± 1.4, n = 283 IHCs from 7 mice) than in Pjvk+/+ mice (13.9 ± 2.6, n = 204 23 
IHCs from 9 mice; t-test, p < 0.001). By contrast, the IK,s and IK,n currents were not affected 24 
(Figure 4B and Figure S7B). The electromotility of OHCs was also impaired in P19-P21 25 
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Pjvk-/- mice, as shown by the reduction of the non-linear cell capacitance, the electrical 1 
correlate of electromotility (Ashmore, 2008) (Figure S7C). Moreover, the total loss of 2 
DPOAE in a large majority of Pjvk-/- mice from P15 on, even at the highest possible stimulus 3 
level of 75 dB SPL, pinpointed a major additional defect of the mechanoelectrical 4 
transduction in OHCs, the main determinant of DPOAEs at high stimulus levels when OHC 5 
electromotility, which amplifies cochlear vibrations at low levels, bears minimal influence 6 
on DPOAE production (Avan et al., 2013). Measurements of the cochlear microphonic 7 
potential at the round window, a far-field electric potential oscillating at the stimulus 8 
frequency that reflects mechanoelectrical transduction currents through OHCs of the basal-9 
most cochlear region, indeed corroborated the DPOAE measurements:  this potential, 10 
recorded for a 5 kHz sound stimulus at 95 dB SPL, was always larger than 10 µV in Pjvk+/+ 11 
mice (n = 8), but fell between 3 µV and 5 µV in the P21 Pjvk-/- mice that displayed residual 12 
DPOAEs (n = 2), and was below 1 µV, indistinguishable from electric artefacts, in the 13 
mutants that had lost their DPOAEs (n = 6). Taken together, these results allowed us to 14 
conclude that the impaired antioxidant defenses in the Pjvk-/- cochlea have an impact on 15 
various electrophysiological properties of the hair cells, particularly mechanotransduction 16 
and K+ current through BK channels. 17 
 Even though mitochondrial defects are a common cause of ROS overproduction, we 18 
didn’t find evidence that mitochondria were damaged, as vulnerability of the mitochondrial 19 
membrane potential, ∆ψm, to the uncoupler carbonyl cyanide 4-20 
(trifluoromethoxy)phenylhydrazone (FCCP) in the organ of Corti and cochlear ganglion was 21 
similar in P17-P30 Pjvk-/- and Pjvk+/+ mice, and transmission electron microscopy of Pjvk-/- 22 
hair cells revealed no mitochondrial abnormalities (Figure S7D and data not shown).  23 
 24 
Pejvakin is a peroxisome-associated protein 25 
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By using Pjvk-/- cochlea as control, we found that neither the commercially available 1 
antibodies nor our initial polyclonal antibody (Delmaghani et al., 2006) specifically 2 
recognized pejvakin (data not shown). Given the limited divergence of the pejvakin amino-3 
acid sequence among vertebrates (97% sequence identity between mice and humans), we 4 
tried to elicit an immune response in Pjvk-/- mice (see Experimental Procedures). The 5 
monoclonal antibody obtained, Pjvk-G21, yielded punctate immunostaining throughout the 6 
cytoplasm of transfected HeLa cells expressing pejvakin, whereas no such staining was 7 
observed in non-transfected cells. Double staining for peroxisome membrane protein 70 8 
(PMP70) demonstrated the colocalization of pejvakin and peroxisomes (Figure S5A). In the 9 
human HepG2 hepatoblastoma cell line, which is particularly rich in peroxisomes, strong 10 
immunolabeling for endogenous pejvakin was associated with the peroxisomes (Figure 5A). 11 
Finally, the specificity of the Pjvk-G21 antibody was demonstrated by the immunoreactivity 12 
of peroxisomes in the hair cells of Pjvk+/+, but not Pjvk-/- mice  (Figure 5B and S5B). 13 
Peroxisomal matrix proteins are imported into the peroxisome by interaction with 14 
peroxin 5 or peroxin 7, via the PTS1 or PTS2 targeting signals (Smith and Aitchison, 2013). 15 
Prediction programs identified no PTS1 or PTS2 motifs in the pejvakin sequence  (Mizuno 16 
et al., 2008), suggesting that pejvakin is a peroxisomal membrane or membrane-associated 17 
protein.  18 
 19 
Ultrastructural abnormalities of peroxisomes in the hair cells of Pjvk-/- mice 20 
We investigated the distribution and morphology of peroxisomes in the Pjvk-/- 21 
cochlea by transmission electron microscopy. Peroxisomes were identified on the basis of 22 
catalase activity detection using 3,3'-diaminobenzidine as substrate. We focused on OHCs, 23 
the first to display a dysfunction in the mutant mice. On P30 but not P15, both the 24 
distribution and shape of peroxisomes differed between Pjvk-/- and Pjvk+/+ mice (Figure 5E). 25 
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In Pjvk+/+ mice, the peroxisomes were restricted to an area immediately below the cuticular 1 
plate, a meshwork of actin filaments under the apical surface of the hair cells. In Pjvk-/- mice, 2 
the peroxisomes located just below the cuticular plate were slightly larger than those in 3 
Pjvk+/+ mice. Strikingly, irregular catalase-containing structures, some of which were 4 
juxtaposed, were present in the perinuclear region, at the immediate vicinity of the nuclear 5 
membrane, of all Pjvk-/- OHCs, but not of Pjvk+/+ OHCs, which never contained any 6 
peroxisome either at this emplacement (Figure 5E). The lack of pejvakin thus results in 7 
peroxisome abnormalities in cochlear OHCs after the onset of hearing. 8 
 9 
Pejvakin is involved in oxidative stress-induced peroxisome proliferation  10 
 In HepG2 cells, protrusions emerging from some peroxisomes, the first step of 11 
peroxisome biogenesis from pre-existing peroxisomes, were immunoreactive for pejvakin. 12 
String-of-beads structures corresponding to elongated and constricted peroxisomes, 13 
preceding final fission (Smith and Aitchison, 2013), were also pejvakin-immunoreactive, 14 
suggesting a role of this protein in peroxisome proliferation (Figure S5C). Peroxisomes 15 
actively contribute to cellular redox balance, by producing and scavenging/degrading H2O2 16 
through a broad spectrum of oxidases and peroxidases (especially catalase), respectively 17 
(Schrader and Fahimi, 2006). Because Pjvk-/- mice displayed features of marked oxidative 18 
stress in the cochlea, we investigated the possible role of pejvakin in peroxisome 19 
proliferation in response to oxidative stress induced by H2O2, which upregulates the 20 
expression of peroxisome biogenesis genes (Lopez-Huertas et al., 2000). Embryonic 21 
fibroblasts derived from Pjvk+/+ and Pjvk-/- mice were exposed to 0.5 mM H2O2 for 4 hours, 22 
and cells were analyzed after 18 hours of incubation in H2O2-free culture medium (see 23 
Experimental Procedures). In unexposed cells, the number of peroxisomes was similar 24 
between the two genotypes (t-test, p = 0.82). After H2O2 treatment, the number of 25 
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peroxisomes was increased by 46% in Pjvk+/+ fibroblasts (p = 0.004) but remained 1 
unchanged in Pjvk-/- fibroblasts (p = 0.83), resulting in a statistically significant difference 2 
between the two genotypes (p < 0.001) (Figures 5C and S6A).  3 
 We then asked whether mutations reported in DFNB9 patients also affect peroxisome 4 
proliferation. To this purpose, we assessed the number of peroxisomes in transfected HeLa 5 
cells producing EGFP alone, EGFP and murine pejvakin, or EGFP and one of the mutated 6 
forms of murine pejvakin carrying the mutations responsible for DFNB59 (p.T54I, 7 
p.R183W, p.C343S, or p.V330Lfs*7). Cells producing the non-mutated pejvakin had larger 8 
numbers of peroxisomes than cells producing EGFP alone, whereas cells producing any of 9 
the mutated forms of pejvakin (mutPjvk-IRES-EGFP) had smaller peroxisome numbers. In 10 
addition, many of these cells contained enlarged peroxisomes, a feature typical of 11 
peroxisome proliferation disorders (Ebberink et al., 2012) (Figure 5D and S6B). Together, 12 
these results strongly suggest that pejvakin is directly involved in the production of new 13 
peroxisomes from pre-existing peroxisomes. 14 
 15 
Upregulation of Pjvk cochlear transcription and peroxisome proliferation in response 16 
to sound 17 
We then asked whether pejvakin is involved in the physiological response to sound. 18 
We first assessed the transcription of Pjvk, and of CypA, Gpx2, c-Dct, and Mpv17 that were 19 
downregulated in Pjvk-/- mice, in microdissected organs of Corti from P21 wild-type mice, 20 
with or without prior sound-stimulation (5-20 kHz, 105 dB SPL for 1 hour; see Extended 21 
Experimental Procedures). Transcript levels were analyzed by quantitative RT-PCR at 22 
various times (1, 3, 6, and 18 hours) after sound-exposure (Figure 6A). Pjvk transcript levels 23 
had increased by factors of 1.9 ± 0.1 and 3.5 ± 0.7 after 1 hour and 6 hours, respectively. 24 
CypA, c-Dct and Mpv17 were also upregulated after 6 hours (by factors of 6.6 ± 1.2, 4.3 ± 25 
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0.6 and 1.5 ± 0.1, respectively), as were c-Fos and Hsp70, used as a positive control, but 1 
Gpx2 was not. Thus, noise-exposure elicits an upregulation of the transcription of Pjvk and 2 
of genes downregulated in Pjvk-/- mice and this effect is dependent on acoustic energy level 3 
(Figure S4B).    4 
Based on this result, we predicted that sound-exposure would lead to peroxisome 5 
proliferation in the auditory system of wild-type mice. Six hours after exposure (5-20 kHz, 6 
105 dB SPL for 1 hour), the numbers of peroxisomes were unchanged (34.5 ± 0.8 and 35.9  7 
± 1.0 per IHC from unexposed and sound-exposed mice, respectively, n = 75 cells from 6 8 
mice, respectively; t-test, p = 0.25). However, at 48 hours, they had markedly increased, by 9 
a factor of 2.3, in both IHCs and OHCs (84.7 ± 5.0 per IHC and 16.5 ± 1.0 per OHC, n = 90 10 
cells and n = 150 cells from 6 mice, respectively) compared to unexposed mice (36.8 ± 3.0 11 
per IHC and 7.3 ± 0.4 per OHC, n = 90 cells and n = 150 cells from 6 mice, respectively; t-12 
test, p < 0.0001 for both comparisons). The number of peroxisomes had also increased, by 13 
35%, in the dendrites of primary auditory neurons (1.7 ± 0.1 and 2.3 ± 0.2 peroxisomes per 14 
µm of neurite length, n = 40 neurites from 5 unexposed and 5 sound-exposed Pjvk+/+mice, 15 
respectively; t-test, p = 0.003).  16 
 17 
Therapeutic approaches in Pjvk-/- mice 18 
We used the classical anti-oxidant drug N-acetyl cysteine (either alone or associated 19 
with α-lipoic acid and α-tocopherol; see Experimental procedures), which was administered 20 
to Pjvk-/- pups. The ABR thresholds of P21 Pjvk-/- pups treated with N-acetyl cysteine alone 21 
(n = 21) were about 10 dB lower than those of untreated Pjvk-/- pups (n = 24) for all 22 
frequencies tested (10, 15, 20, and 32 kHz; t-test, p < 0.001 for all comparisons) (Figure 23 
7A). N-acetyl cysteine principally affected the amplitude of the ABR wave I elicited at 105 24 
dB SPL, which was similar to that in age-matched Pjvk+/+ mice and greater than that in 25 
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untreated Pjvk-/- mice (4.35 ± 1.16 µV, n = 21; 4.36 ± 1.15 µV, n = 18; and 1.88 ± 1.07 µV, n 1 
= 24, respectively; ANOVA, p < 0.001) (Figure 7B). EEBRs were more resistant to the 2 
high-rate electrical stimulation in treated than in untreated mutant mice (Figure 7C). 3 
Conversely, N-acetyl cysteine had no beneficial effect on OHCs (data not shown). The 4 
association of N-acetyl cysteine with α-lipoic acid and α-tocopherol did not perform any 5 
better (data not shown). 6 
Full recovery of the neuronal phenotype was achieved by the intracochlear injection 7 
of AAV8-mediated pejvakin cDNA (see above). This viral vector does not transduce hair 8 
cells, so OHCs remained non-functional (no detectable DPOAE, n = 9), and ABR wave-I 9 
amplitude, which is controlled by IHC function, did not differ significantly between Pjvk-/- 10 
mice receiving AAV8 containing the pejvakin cDNA (3.3 ± 1.8 µV, n = 9), the EGFP cDNA 11 
only (3.2 ± 1.3 µV, n = 5), or with no injection (2.7 ± 1.4 µV, n = 11) (ANOVA, p = 0.54). 12 
We thus investigated whether AAV2/8, which transduces hair cells only (Figure S2B), could 13 
rescue the hair-cell phenotype in Pjvk-/- mice. The auditory function of Pjvk-/- mice (n = 7, 14 
four pups per cage in every experiment) receiving intracochlear injections of AAV2/8-15 
pejvakin cDNA (Pjvk-IRES-EGFP) on P3 was assessed on P21, and the percentage of 16 
transduced IHCs and OHCs was evaluated in each injected and contralateral cochlea, on the 17 
basis of EGFP fluorescence. Improvements in ABR thresholds of 20 to 30 dB SPL with 18 
respect to untreated mice were observed for frequencies between 10 and 20 kHz (t-test, p < 19 
0.001 for all comparisons; Figure 7D). With the same vector expressing the EGFP cDNA 20 
only (n = 6), ABR thresholds were similar to those of untreated Pjvk-/- mice (n = 10) (81.6 21 
vs. 78.6 dB SPL for 10 kHz, p = 0.64). A partial reversion of the OHC dysfunction was 22 
obtained, with detectable DPOAEs in pejvakin cDNA-treated cochleas (threshold 54.0 ± 23 
10.7 dB), but not in contralateral, untreated cochleas (Figure 7F). DPOAE thresholds were 24 
linearly correlated (r2 = 0.74, p < 0.001) with the number of EGFP-tagged OHCs (Figure 25 
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7G), suggesting that the normalization of DPOAE thresholds may be possible if all OHCs 1 
could be transduced. The latency of the ABR wave I in response to a 105 dB SPL 2 
stimulation decreased significantly (1.38 ± 0.11 ms vs. 1.53 ± 0.10 ms; t-test, p = 0.026) 3 
(Figure 7E), and its amplitude increased into the normal range (7.34 ± 0.80 µV for the 4 
treated ears, n = 6, vs. 2.93 ± 0.92 µV for the contralateral, untreated ears; paired t-test, p < 5 
0.001) (Figure 7H), in relation to the number of EGFP-tagged IHCs (r2 = 0.89 for wave I 6 
amplitude, p < 0.001; Figure 7I). No correction of the interwave I-IV latency was observed, 7 
as expected (data not shown).  8 
Finally, we investigated the effect of the transduction of Pjvk-/- IHCs by AAV2/8-9 
pejvakin cDNA on their peroxisomes. Before sound-exposure, the numbers of peroxisomes 10 
in IHCs of Pjvk-/- and AAV2/8-Pjvk Pjvk-/- mice did not differ from that of Pjvk+/+ mice 11 
(30.5 ± 1.9, 32.3 ± 2.1, and 36.8  ± 3.0 peroxisomes per IHC, n = 60 cells from 4 Pjvk-/- and 12 
4 AAV2/8-Pjvk Pjvk-/- mice, and n = 90 cells from 6 Pjvk-+/+ mice, respectively; respective t-13 
test, p = 0.11 and p = 0.30).  By contrast, 48 hours after sound-exposure (5-20 kHz) at 105 14 
dB SPL for 1 hour, the number of peroxisomes had decreased by 63% in Pjvk-/- IHCs (30.5 ± 15 
1.9 and 11.2 ± 1.3 peroxisomes per IHC, n = 75 cells from 5 unexposed and 5 sound-16 
exposed Pjvk-/- mice, respectively; t-test, p < 0.0001), and enlarged PMP70-labeled 17 
structures were present close to the nucleus (Figure 7J). In response to the same sound but of 18 
a lower intensity, i.e. 97 dB SPL for 1 hour, the number of peroxisomes was unchanged in 19 
Pjvk-/- IHCs  (30.5 ± 1.9 and 34.6 ± 2.3 peroxisomes per IHC, n = 60 cells from 4 unexposed 20 
and 4 sound-exposed Pjvk-/- mice, respectively; t-test, p = 0.17), and no enlarged PMP70-21 
stained structures were detected (data not shown). Thus, depending on the acoustic energy of 22 
the sound stimulation, in the absence of pejvakin, peroxisomes failed to proliferate in IHCs 23 
(both at 105 dB SPL and 97 dB SPL), and even degenerated (at 105 dB SPL). In AAV2/8-24 
Pjvk injected Pjvk-/- mice exposed to 105 dB SPL for 1 hour, enlarged PMP70-labeled 25 
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structures were no longer detected in transduced IHCs and the number of peroxisomes 1 
increased by 35% (32.3 ± 2.1 and 43.7 ± 3.0 peroxisomes per IHC, n = 60 cells from 2 
unexposed and exposed transduced Pjvk-/- IHCs, respectively, t-test, p = 0.002) (Figure 7J). 3 
We conclude that pejvakin re-expression fully protects Pjvk-/- IHCs from peroxisome 4 
degenerescence and partially restores their impaired adaptive proliferation. 5 
 6 
DISCUSSION 7 
Noise overexposure, a major threat to hearing, affects 15% of people between the 8 
ages of 20 and 69 years. There are currently no efficient methods for curing noise-induced 9 
hearing loss (NIHL), and we still know little about the underlying pathogenic processes. We 10 
describe here a genetic form of NIHL, by showing that pejvakin deficiency in mice and 11 
DFNB59 patients leads to hypervulnerability to sound, due to a peroxisomal deficiency. 12 
This is the first reported peroxisomal cause of an isolated (non-syndromic) form of inherited 13 
deafness. The peroxisome emerges as a key organelle in the redox homeostasis of the 14 
auditory system, for coping with the overproduction of ROS induced by high levels of 15 
acoustic energy. 16 
Acoustic energy is the main determinant of NIHL. The LEX,8 hour (for level of 17 
exposure over an 8-hour workshift) index has been defined such that an LEX,8 hour of X dB 18 
delivers the same energy as a stable sound of X dB played over a period of eight hours. 19 
Chronic occupational exposures to less than 85 dB (or 80 dB, depending on the country) are 20 
deemed safe. In Pjvk-/- mice, a single exposure to 63 dB LEX,8 hour increased hearing 21 
thresholds by 30 dB, with full recovery occurring after about two weeks. By contrast, a ten-22 
times more energetic exposure to a LEX,8 hour of 73 dB in wild-type mice of the same strain 23 
produces only an 18 dB shift in threshold, with a recovery time of 12 hours (Housley et al., 24 
2013). This hypersensitivity of Pjvk-/- mice to noise suggests that the LEX,8 hour, of about 83 25 
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dB for a cage of 10 pups, is sufficient to account for permanent hearing loss in these Pjvk-/- 1 
pups, whilst some of those housed in small numbers in quiet rooms can display near-normal 2 
hearing thresholds (see Figure 1C). Likewise, the auditory function of DFNB59 patients was 3 
transiently affected by a 57 dB LEX,8 hour exposure, routinely used in ABR tests. 4 
NIHL involves the excessive production of ROS, overwhelming the anti-oxidant defense 5 
system and causing irreversible oxidative damage to DNA, proteins, and lipids within the 6 
cell (Henderson et al., 2006). Noise-induced oxidative stress results in the production of 7 
H2O2 and other ROS as by-products, thought to derive from the intense sollicitation of 8 
mitochondrial activity. Several mouse mutants with mitochondrial defects are prone to 9 
NIHL (Ohlemiller et al., 1999), including mice lacking sirtuin 3, a mitochondrial NAD+- 10 
dependent deacetylase (Brown et al., 2014). Our studies of pejvakin-deficient mouse 11 
mutants and rescue experiments targeting the hair cells and auditory neurons unambiguously 12 
show that IHCs, OHCs, primary auditory neurons and neurons of the cochlear nucleus are 13 
hypervulnerable to sound in the absence of pejvakin, which is consistent with previous 14 
results showing that hair cells and neurons of the auditory system are targets of NIHL 15 
(Wang et al., 2002; Kujawa & Liberman, 2009; Imig and Durham, 2005). However, our 16 
study goes one step further, by implicating a possible common mechanism:  peroxisomal 17 
failure, the importance of which is demonstrated by the impairment of the redox 18 
homeostasis caused by pejvakin deficiency. It also reveals a major cause of the unusually 19 
high level of phenotypic variability observed in pejvakin-deficient mice and humans: the 20 
difference in sound-exposure and the inability of the defective peroxisomes to cope with the 21 
resulting activity-dependent oxidative stress. Incidentally, this can account for the apparent 22 
paradox that mice carrying the R183W mutation in pejvakin displayed a much more severe 23 
neural pathway defect than the Pjvk-/- mice (Delmaghani et al., 2006).  Due to the 24 
preservation of hair cell functions, the auditory neurons of R183W mutant mice should be 25 
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strongly stimulated, whereas the early permanent damage to cochlear hair cells in Pjvk-/- 1 
mice acts as a protective "muffler" of the neuronal pathway. 2 
In mammals, the number and metabolic functions of peroxisomes differ between cell 3 
types. However, all cell types are able to adapt rapidly to modifications in physiological 4 
conditions by changing the number, shape, size, and molecular content of peroxisomes, 5 
resulting in considerable functional plasticity of these organelles (Schrader et al., 2012; 6 
Smith and Aitchison, 2013). Our experiments on Pjvk-/- and Pjvk+/+ mouse embryonic 7 
fibroblasts stressed with H2O2 showed that pejvakin is critically involved in the oxidative 8 
stress-induced proliferation of peroxisomes through growth and fission of pre-existing 9 
peroxisomes. Although the molecular machinery underlying this adaptive process is still 10 
poorly understood, the specific involvement of Pex11α that recruits COP I has been reported 11 
(Li et al., 2002; Passreiter et al., 1998). Of note, the absence of pejvakin only affects the 12 
proliferation of peroxisomes from pre-existing peroxisomes, but not the constitutive 13 
biogenesis of this organelle. Accordingly, structural abnormalities of peroxisomes in Pjvk-/- 14 
mice became apparent only after hearing onset, in the context of the oxidative stress 15 
produced by noise-exposure. By contrast, the PEX gene defects causing Zellweger syndrome 16 
spectrum (ZSS) disorders (Waterham & Ebberink, 2012) and rhizomelic chondrodysplasia 17 
punctata affect the constitutive biogenesis of peroxisomes. Hearing impairment in ZSS 18 
disorders involves a severe impairment of neuronal conduction, and has been attributed to 19 
defects in the synthesis of two essential myelin sheath components — plasmalogens and 20 
docosahexaenoic acid —, which is critically dependent on peroxisomes. Our results suggest 21 
that ZSS also includes a defective redox balance in the hair cells and neurons of the auditory 22 
system.  23 
In the context of noise-exposure, the upregulation of Pjvk transcription in the cochlea 24 
and the subsequent peroxisome proliferation in the hair cells and auditory neurons of wild-25 
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type mice suggest that pejvakin-dependent peroxisome proliferation in the auditory system 1 
is part of the physiological response to high levels of acoustic energy that result in increased 2 
amounts of ROS. This and the marked oxidative stress detected in the Pjvk-/- cochlea imply 3 
that the proliferation of peroxisomes plays an anti-oxidant role, similar to that reported in 4 
other cell types (Santos et al., 2005; Diano et al., 2011). The rapid elevation of the hearing 5 
threshold in Pjvk-/- mice in response to low-energy sounds and the increase in interwave I-IV 6 
latency observed in DFNB59 patients within a few seconds are consistent with an activity-7 
dependent H2O2 production that, due to impaired cellular redox homeostasis, results in 8 
concentrations of H2O2 high enough to impact on the activity of various target proteins 9 
including ion channels and transporters (Rice, 2011). The worsening of hearing sensitivity, 10 
two days later, in the mutant mice lacking pejvakin, exacerbated by putting back the mice in 11 
a noisy environment, fits the picture of the absence of sound-induced biogenesis of 12 
peroxisomes (with their degeneration occurring in a high acoustic energy environment). We 13 
thus conclude that the hypervulnerability of Pjvk-/- mice and DFNB59 patients to sound does 14 
not result simply from an exacerbation, by sound, of a pre-existing redox balance defect, but 15 
is the consequence of the impaired adaptive proliferation of peroxisomes in the absence of 16 
pejvakin. Both the defective peroxisome proliferation in IHCs of Pjvk-/- mice in response to 17 
sound-exposure and its partial recovery by pejvakin cDNA transfer support this conclusion. 18 
A full recovery of the adaptive peroxisome proliferation produced by sound-exposure may 19 
require higher concentrations of pejvakin or the sound-induced dynamic modulation of Pjvk 20 
expression (see Figure 6A), which is missing in our rescue experiments (the expression of 21 
the pejvakin cDNA being driven by a constitutive promoter). 22 
 In patients with hearing impairment, the amplification of sound by hearing aids or 23 
direct electrical stimulation of the auditory nerve by a cochlear implant delivers a stimulus 24 
with an energy level similar to that shown here to worsen the hearing impairment of Pjvk-/- 25 
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mice within one minute of sound exposure. Therefore, in cases of peroxisomal deficiency, as 1 
in DFNB59, specific protection against redox homeostasis failure is essential, and patients 2 
with such conditions should avoid noisy environments. N-acetyl cysteine was the only 3 
antioxidant drug tested here to display some, albeit limited, efficacy. By contrast AAV-4 
mediated gene therapy, could potentially provide full protection. Finally, deciphering the 5 
sound stress-induced protective signaling pathway involving pejvakin, and possibly 6 
cyclophilin A, c-dopachrome tautomerase, and Mpv17, might lead to the discovery of 7 
therapeutic agents for NIHL. 8 
 9 
EXPERIMENTAL PROCEDURES 10 
 11 
Audiological studies in mice 12 
Auditory tests were performed in an anechoic room, on anesthetized animals for which core 13 
temperature was maintained at 37°C (see Extended Experimental Procedures).  14 
 15 
Audiological tests in patients 16 
Informed consent was obtained from all the subjects included in the study. Pure-tone 17 
audiometry was performed, with air- and bone-transmitted tones. Hearing impairment was 18 
assessed objectively, by measuring ABRs and transient-evoked otoacoustic emissions 19 
(TEOAEs). The nonlinear TEOAE recording procedure was used (derived from the ILO88 20 
system), making it possible to extract TEOAEs from linear reflection artifacts from the 21 
middle ear, and to evaluate background noise. TEOAE responses were analyzed in 1 kHz-22 
wide bands centered on 1, 2, 3 and 4 kHz. 23 
 24 
Generation of an anti-pejvakin monoclonal antibody  25 
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The 3’-end of the coding sequence of the Pjvk cDNA (accession number NM_001080711.2) 1 
was inserted into a pGST-parallel-2 vector (derived from pGEX-4T-1; Amersham). The 2 
resulting construct, encoding the C-terminal region of pejvakin (residues 290-352; accession 3 
number NP_001074180.1) fused to an N-terminal glutathione S-transferase tag, was 4 
introduced into E. coli BL21-Gold (DE3) competent cells (Stratagene). The pejvakin protein 5 
fragment was purified on a glutathione-Sepharose 4B column, then subjected to size-6 
exclusion chromatography and used as the antigen for immunization. Antibodies were 7 
produced by immunizing Pjvk-/- mice. An IgG monoclonal antibody (KD of 6 x 10-8 M), 8 
Pjvk-G21, was selected by ELISA on immunogen-coated plates.  9 
 10 
Determination of total and oxidized glutathione  11 
Total glutathione (GSH + GSSG) and oxidized glutathione (GSSG) levels were determined 12 
as described by Rahman et al. (2006). Total glutathione and GSSG levels were evaluated by 13 
spectrometry at 405 nm. GSH concentration was calculated by subtracting the concentration 14 
of GSSG from the total glutathione concentration. Three independent experiments were 15 
performed, in P21 Pjvk+/+ and Pjvk-/- mice. 16 
 17 
Statistical analyses 18 
Statistical analyses were performed using GraphPad. Data were analyzed by either paired or 19 
unpaired Student’s t-tests, and, for more than two groups, we used one-way or two-way 20 
ANOVA analyses of variance. Statistical significance is defined as p < 0.05 and indicated  21 
by asterisks. 22 
 23 
SUPPLEMENTAL INFORMATION 24 
  24 
The supplemental information includes Extended Experimental Procedures, seven figures, 1 
and one table. 2 
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 FIGURE LEGENDS 22 
Figure 1. Hearing loss variability and greater sensitivity to controlled sound-exposure 23 
in Pjvk-/- mice. (A) ABR thresholds at 10 kHz in P30 Pjvk+/+ (n = 26 mice) and Pjvk-/- (n = 24 
48 mice) littermates. (B) DPOAE thresholds at 10 kHz in P30 Pjvk+/+ (n = 14 mice) and 25 
Pjvk-/- (n = 48 mice) littermates. In ears with no DPOAE, even at 75 dB SPL (the highest 26 
sound intensity tested), DPOAE thresholds were arbitrarily set at 80 dB SPL. (C) 27 
Relationship between the number of pups raised together (determining sound levels in the 28 
immediate environment) and ABR thresholds at 10 kHz in P21 Pjvk-/- pups. Inset: Time-29 
frequency analysis of a mouse pup’s vocalization. Pup calls from P0 to P21 form harmonic 30 
series of about 5 kHz, with the most energetic harmonic at about 10 kHz. In a 12-pup litter, 31 
  28 
call levels reach 105 ± 5 dB SPL at the entrance to the ear canals of the pups. (D) ABR 1 
thresholds at 10 kHz in P30 Pjvk+/+ and Pjvk-/- mice before (dots) and after (crosses) 2 
controlled sound-exposure. n.s., not significant; *** p < 0.001. 3 
 4 
Figure 2. Effects on auditory function of brief exposure to moderately intense stimuli 5 
in Pjvk+/+, Pjvk-/-, and Pjvkfl/flMyo15-cre+/- mice. (A-C) ABR wave I amplitude (A), 6 
DPOAE amplitude (B) and ABR interwave I-IV latency (C) in Pjvk+/+, Pjvk-/- and 7 
Pjvkfl/flMyo15-cre+/- mice, before (dots) and after (crosses) controlled sound-exposure, 8 
revealing the hypervulnerability to sound of both types of cochlear hair cells (IHCs and 9 
OHCs) and the auditory pathway, only in Pjvk-/- mice. (D) EEBR wave E IV amplitude 10 
before and after controlled electrical exposure in Pjvk-/- and Pjvkfl/flMyo15-cre+/- mice, 11 
abnormal and hypervulnerable only when pejvakin is absent from auditory neurons (Pjvk-/- 12 
mice). (E and F) Examples of ABRs in Pjvk-/- and Pjvkfl/flMyo15-cre+/- mice: the latency of 13 
wave I is affected by controlled sound-exposure in both mutant mice, and wave IV displays 14 
an additional increase in latency only in Pjvk-/- mice. (G-I) Examples of EEBRs in Pjvk+/+ 15 
(G), Pjvk-/- (H), and Pjvkfl/flMyo15-cre+/- (I) mice; EEBRs are affected by controlled 16 
electrical exposure only in Pjvk-/- mice. (J-L) Neuronal function rescue in Pjvk-/- mice by 17 
transduction with AAV8-Pjvk: effects on ABR interwave I-IV latency (J), on EEBR wave E 18 
IV amplitude and its hypervulnerability (K), and on EEBR interwave E II-E IV latency (one 19 
example is shown in L, to be compared with H). Vertical arrows indicate the positions of 20 
waves I and IV on ABR traces, and of waves E II and E IV on EEBR traces. n.s., not 21 
significant; *** p < 0.001. Error bars represent the SD.  See also Figure S2A. 22 
 23 
Figure 3. Hypervulnerability to sound in DFNB59 patients. (A) ABR waves I, III, and V 24 
(vertical arrows) in one ear of a patient carrying the PJVK p.T54I mutation, in response to 25 
  29 
250, 500, and 1000 impulse stimuli (clicks) at 99 dB nHL. (B) Repeated ABRs after 10 1 
minutes of silence, with an even larger vulnerability of waves I, III, and V. (C and D) 2 
Distributions of the amplitude (C) and latency (D) of ABR wave V in the tested sample of 3 
p.T54I patients (n = 8 ears), and in a control group of patients (n = 13) with cochlear hearing 4 
impairment and matched ABR thresholds, before and after exposure to clicks #250 to #1000. 5 
Boxes extend from the 25th to the 75th percentile. Horizontal bars and vertical bars indicate 6 
median values and extremes, respectively. Unlike the unaffected controls, all p.T54I patients 7 
displayed markedly decreased amplitudes and increased latencies. 8 
 9 
Figure 4. Oxidative stress and ROS-induced cell damage in the Pjvk-/- cochlea. (A) 10 
Lower reduced-glutathione (GSH) (left bar chart) and higher oxidized-glutathione (GSSG) 11 
(middle bar chart) contents, and lower GSH:GSSG ratio, in P21 Pjvk-/- than Pjvk+/+ mice 12 
(right bar chart). Error bars represent the SEM of 3 independent experiments. See also 13 
Figure S3.  (B) Marked decrease in the BK α-subunit expression in Pjvk-/- IHCs. Left: P20 14 
Pjvk+/+ and Pjvk-/- IHCs, immunolabeled for the BK α-subunit. Scale bars are 5 µm. Right: 15 
quantitative analysis of BK channel clusters. Error bars represent the SD.  See also Figure 16 
S7B. * p < 0.05,  *** p < 0.001.  17 
 18 
Figure 5. Pejvakin is a peroxisome-associated protein involved in the oxidative stress-19 
induced peroxisomal proliferation. (A, B) Immunolabeling of peroxisome membrane 20 
protein 70 (PMP70) and endogenous pejvakin in a HepG2 cell (A) and two P20 Pjvk+/+ and 21 
Pjvk-/- IHCs (B) showing their colocalization. See also Figure S5B.	   (C) Number of 22 
peroxisomes per Pjvk+/+ and Pjvk-/- MEFs subjected to 0.5 mM H2O2 compared to untreated 23 
(n = 30 cells for each condition). The number of peroxisomes increased only in Pjvk+/+cells. 24 
See also Figure S6A. (D) Untransfected HeLa cells (NT), and transfected cells producing 25 
EGFP alone or with either the wild-type pejvakin (Pjvk) or various mutated forms (different 26 
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missense mutations, p.T54I, p.R183W, p.C343S, and p.V330Lfs*7, reported in DFNB59 1 
patients). Right panel: Bar chart showing the numbers of peroxisome per cell 48 hours after 2 
transfection. There were 33% more peroxisomes in cells producing Pjvk (n = 200) than in 3 
cells producing EGFP alone (n = 150). Left panel: For every range of enlarged peroxisome 4 
size, x (0.6-0.8 µm, 0.8-1.0 µm, and > 1.0 µm), in two perpendicular directions, the 5 
proportion of cells containing at least one peroxisome in that range is higher for cells 6 
producing any mutated form of pejvakin (n = 80) than for cells producing Pjvk (n = 320). 7 
See also Figure S6B. (E) Abnormalities in shape and distribution of peroxisomes in mature 8 
Pjvk-/- OHCs detected by transmission electron microscopy. P30 Pjvk+/+ (left panel) and 9 
Pjvk-/- (middle and right panels) OHCs. Insets (middle panel) show enlarged views of 10 
individual peroxisomes : peroxisomes are grouped just under the cuticular plate (CP) 11 
(arrowheads), with none detected in the perinuclear region (n = 33 sections, upper bar chart). 12 
In Pjvk-/- OHCs, some peroxisomes remain under the cuticular plate (arrowheads), but 13 
catalase-containing structures, misshapen peroxisomes (arrows), are detected in the 14 
perinuclear region  (n = 24 sections, upper bar chart). Peroxisomes located under the 15 
cuticular plate are larger in Pjvk-/- (n = 92 peroxisomes) than in Pjvk+/+ (n = 89 peroxisomes) 16 
OHCs (lower bar chart). N: cell nucleus. ** p < 0.01, *** p < 0.001. Error bars represent the 17 
SEM.  Scale bars are 2 µm in (A) and (B), and 0.5 µm in (E).	  18 
 19 
Figure 6. Effect of exposure to loud sounds on the cochlear expression of Pjvk and the 20 
number of peroxisomes in cochlear hair cells and ganglion neurons. (A) Pjvk and c-Dct, 21 
CypA, Mpv17, Gpx2 transcript levels (genes downregulated in Pjvk-/- mice) assessed by  22 
quantitative RT-PCR in the organ of Corti of P21 Pjvk+/+ mice, 1, 3, 6, and 18 hours after 23 
sound-exposure (5-20 kHz, 105 dB SPL for 1 hour). Pjvk transcript levels increased by a 24 
factor of 2 to almost 4 from 1 to 6 hours, and returned to pre-exposure levels at 18 hours. 25 
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The levels of c-Dct, CypA, and Mpv17 but not Gpx2 transcripts followed similar time 1 
courses. The levels of c-Fos and Hsp70 transcripts were used as positive controls. See also 2 
Figure S4B. (B) Peroxisome proliferation in the hair cells and cochlear ganglion neurons of 3 
P21 Pjvk+/+ mice after sound-exposure (same conditions as in A). Peroxisomes counted 48 4 
hours after exposure, in OHCs and IHCs (whole-mount preparations), and in the dendrites of 5 
ganglion neurons (cryosections). OHCs, IHCs, and neuronal processes, stained for F-actin, 6 
myosin VI, and neurofilament protein NF200, respectively, allow to identify peroxisomes 7 
located inside hair cells or neurons. For OHCs, both a lateral view and a transverse optical 8 
section at the level of the cuticular plate (see scheme on the right) are shown. The number of 9 
peroxisomes increased in OHCs, IHCs, and dendrites after sound-exposure. The 10 
peroxisomes are located below the cuticular plate (CP) and throughout the cytoplasm in 11 
OHCs and IHCs, respectively. N: cell nucleus. *** p < 0.001. Error bars represent the SEM. 12 
Scale bars are 5 µm.  13 
 14 
Figure 7. Therapeutic approaches in Pjvk-/- mice. (A-C) Effect of N-acetyl cysteine on 15 
auditory function in Pjvk-/- mice. (A) ABR thresholds in untreated and N-acetyl cysteine 16 
(NAC)-treated P21 Pjvk-/- mice, showing a moderate improvement in treated mice. (B) ABR 17 
wave I amplitude (which relates to the number of synchronously responding primary 18 
auditory neurons) for 10 kHz tone bursts in Pjvk+/+, untreated Pjvk-/-, and NAC-treated Pjvk-/- 19 
mice at P21, showing normalization in treated mice. (C) EEBR wave E IV amplitude before 20 
(dots) and after (crosses) controlled electrical stimulation of the cochlear nerve at 200 21 
impulses/s for 1 minute in Pjvk+/+, untreated Pjvk-/-, and NAC-treated Pjvk-/- mice, showing 22 
that the hypersensitivity of the auditory pathway in Pjvk-/- mice responds to NAC treatment. 23 
(D-I) AAV2/8-mediated transfer of the pejvakin cDNA in the cochlea of Pjvk-/- mice. See 24 
also Figure S2B. (D) Beneficial effect of viral transduction on ABR thresholds at 10, 15, and 25 
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20 kHz in treated (AAV2/8-Pjvk) vs. untreated Pjvk-/- mice. (E) Improved ABR wave I 1 
latency in treated vs. contralateral, untreated ears. (F, H) Improved DPOAE threshold (F) 2 
and ABR wave I amplitude (H) at 10 kHz in treated vs. contralateral, untreated ears. (G) 3 
Correlation between DPOAE thresholds and the proportion of EGFP-tagged (i.e. 4 
transduced) outer hair cells (OHCs). Note that the six untreated ears displayed no recordable 5 
DPOAE (threshold arbitrarily set at 80 dB SPL, red diamond). (I) Correlation between ABR 6 
wave I amplitude at 10 kHz, 105 dB SPL and the proportion of EGFP-tagged (i.e. 7 
transduced) IHCs. Error bars represent the SD. (J) Beneficial effect of pejvakin cDNA 8 
transfer on impaired sound-induced proliferation of peroxisomes in IHCs of Pjvk-/- mice. 9 
Upper and lower panels illustrate and quantify (bar charts) the decreased number of 10 
peroxisomes (with some peroxisomes displaying structural abnormalities, arrowhead) in 11 
untreated mice 48 hours after sound-exposure (5-40 kHz, 105 dB SPL for 1 hour) and the 12 
partial recovery of the adaptive peroxisome proliferation in treated mice, respectively. Error 13 
bars represent the SEM. n.s., not significant; * p < 0.05, ** p < 0.01, *** p < 0.001.  14 
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Supplemental Information 1 
EXTENDED EXPERIMENTAL PROCEDURES 2 
Animal handling 3 
Animals were housed in the Institut Pasteur animal facilities, which are accredited by the 4 
French Ministry of Agriculture for experimentation on live mice (accreditation 75-15-01, 5 
issued on September 6th, 2013 in application of the French and European regulations on the 6 
care and protection of laboratory animals (EC Directive 2010/63, French Law 2013-118, 7 
February 6th, 2013). The corresponding author confirms that the protocols were approved by 8 
the veterinary staff of the Institut Pasteur animal facility, and were performed in accordance 9 
with the NIH Animal Welfare Insurance #A5476-01 issued on July 31st, 2012.  10 
 11 
Gene targeting, genotyping, and RT-PCR 12 
We designed a targeting vector, in which exon 2 of Pjvk and the neomycin selection cassette 13 
(PGK-neo) were flanked by loxP sites. A negative selection cassette encoding the diphtheria 14 
toxin A fragment was inserted at the 3’-end of the Pjvk targeting sequence (Figure S1A). 15 
CK35 embryonic stem (ES) cells (Kress et al., 1998), derived from a 129/Sv mouse embryo, 16 
were electroporated with the purified, linearized targeting vector, and plated on G418 17 
selective medium, as previously described (Matise et al., 1999). Approximately 300 18 
recombinant ES cell clones were obtained, 12 of which were correctly targeted. The 19 
homologous recombinant event was confirmed by PCR, with primers specific for the 5' and 20 
3' genomic sequences outside the region used in the targeting vector, and specific for the 21 
PGK-neo sequence. The sequences of the PCR primers used to genotype the floxed Pjvk 22 
allele are available on request. The integration of the recombinant DNA construct was 23 
confirmed by Southern blot analysis and PCR amplification of genomic DNA extracted 24 
from mouse tails. Two independent clones were used to create chimeric mice displaying 25 
 2 
germline transmission, by injection into C57BL/6J blastocysts. Male chimeras were crossed 1 
with C57BL/6J females to produce heterozygous animals. Mice heterozygous for the floxed 2 
Pjvk allele were crossed with PGK-crem deleter mice carrying the cre recombinase gene 3 
driven by the early-acting ubiquitous phosphoglycerate kinase-1 gene promoter (Lallemand 4 
et al., 1998), to obtain Pjvk-knockout (Pjvk-/-) mice. The targeted deletion of exon 2 was 5 
confirmed by PCR analysis. 6 
Mice with a conditional knockout of Pjvk (Pjvkfl/flMyo15-cre+/-), in which expression of the 7 
deleted Pjvk was restricted to the inner ear sensory cells, were generated by crossing mice 8 
carrying the floxed Pjvk allele with transgenic mice expressing the Cre recombinase gene 9 
under the control of the myosin-15 gene promoter (Caberlotto et al., 2011). Auditory 10 
function was analyzed in ubiquitous knockout and conditional knockout mice. All studies 11 
were performed in a C57BL/6J-129/Sv mixed genetic background. 12 
For RT-PCR analysis of Pjvk transcript levels, total RNA was extracted from the inner ears 13 
of Pjvk+/+ and Pjvk-/- P7 mice with the NucleoSpin® RNA II kit (Macherey-Nagel). The 14 
sequences of the PCR primers used to characterize the Pjvk transcript (Figure S1B) are 15 
available on request. 16 
 17 
Auditory tests, controlled sound-exposure, and controlled electrical stimulation of the 18 
auditory nerve in mice 19 
Mice were anesthetized by intraperitoneal injection of a mixture of ketamine and 20 
levomepromazin (100 mg/kg: 5 mg/kg), and their core temperature was maintained at 37°C 21 
with the aid of a servo-controlled heating pad. The DPOAE at a frequency 2f1-f2 was 22 
recorded in response to two primary tones of similar energy levels, f1 and f2, with f2/f1 = 1.20 23 
(CubeDis system, Mimosa Acoustics; ER10B microphone, Etymotic Res.). Frequency f2 was 24 
swept at 1/10th octave steps from 4 to 20 kHz, and DPOAE threshold was plotted against 25 
 3 
frequency f2 (primary tone levels increased from 20 to 70 dB SPL in 10 dB steps, then to 75 1 
dB SPL). The DPOAE threshold was defined as the smallest primary level eliciting a 2 
detectable DPOAE. The ABRs in response to calibrated short tone bursts in the 5-40 kHz 3 
range (repetition rate 17/s) were derived by the synchronous averaging of 4 
electroencephalograms recorded between subcutaneous stainless steel electrodes at the 5 
vertex and ipsilateral mastoid, with the help of a standard digital averaging system 6 
(CED1401+). A hundred responses to the tone bursts were averaged, except within 10 dB of 7 
the ABR threshold (defined as the smallest tone-burst level giving rise to at least one 8 
repeatable wave above background noise levels, 150 nV in an anesthetized animal), for 9 
which 300 tone bursts were used. Once ABR thresholds had been assessed, ABRs in 10 
response to 95 and 105 dB SPL tone bursts (100 averages) were collected for the analysis of 11 
suprathreshold ABR waveforms, amplitudes and latencies. Controlled sound-exposure was 12 
applied with the same acoustic probe used for ABRs, without moving the sound delivery 13 
system, so that pre- and post-exposure ABRs shared the same calibration. The intense 14 
stimuli were the same tone bursts used for ABR measurements at 105 dB SPL, presented 15 
1000 times, at the same repetition rate of 17/s. 16 
The eighth cranial nerve was stimulated electrically with a silver electrode placed in the 17 
round-window niche and excited by biphasic electrical impulses (neutral electrode in neck 18 
muscles; peak amplitude of electrical stimulus about 0.5 V; duration of the positive and 19 
negative phases 150 µs; adjustable repetition rate). EEBRs were extracted with the same 20 
setup as for ABRs (Roux et al., 2006), in response to 100 electrical impulses presented with 21 
alternating polarities (repetition rate 17/s). The EEBR threshold was defined as the smallest 22 
electrical amplitude eliciting repeatable waves above the level of background noise (the 23 
same as for ABRs), labeled from E II to E IV in reference to their ABR equivalents, II-IV 24 
(Henry, 1979). Controlled electrical stimulation was applied at 5 dB above the EEBR 25 
 4 
detection threshold, with a 200 Hz repetition rate. The silver electrode on the round window 1 
was occasionally also used to record compound action potentials (CAPs) in response to the 2 
same tone bursts used for ABR studies (means of 32 presentations, repetition rate 17/s), 3 
before EEBR data collection. These recordings were used to check that CAP thresholds and 4 
ABR thresholds were within 2 dB of each other at all frequencies, and the exact position of 5 
ABR wave I could be ascertained form the larger wave N1, its equivalent on CAP 6 
recordings. This was particularly important in mice with an abnormally small wave I, to 7 
prevent incorrect identifications (when wave I was reduced to a very small flattened 8 
deflection resembling a summating potential, the slightly larger wave II might have been 9 
erroneously labeled wave I on ABR recordings, whereas wave N1, even when small, 10 
retained its characteristic shape). 11 
The round-window electrode also provided access to the cochlear microphonic potential 12 
(CM), with the same setting used for CAP measurements, except that the stimulus polarity 13 
was fixed for CM recordings, instead of alternating between rarefaction and condensation 14 
tone-bursts for CAP detection. CM is a far-field potential resulting from mechanoelectrical 15 
transduction currents through the OHCs at the basal end of the cochlea, near the collecting 16 
electrode, and is an oscillating change in electric potential at the stimulus frequency. 17 
Although its shape is closely similar to that of the stimulus that activates the sound-18 
delivering earphone, it was easily separated from a possible electric artefact radiated by the 19 
earphone by its delay of about 0.5 ms after stimulus onset, in relation to sound propagation 20 
along the tubing system that connected the earphone to the ear canal of the mouse. Its peak-21 
to-peak amplitude was measured for a stimulus of 5 kHz (a frequency much lower than the 22 
best frequency of the responding OHCs, so that CM was independent of their electromotility 23 
status) presented at 95 dB SPL.  24 
 25 
 5 
Controlled sound-exposure in DFNB59 patients 1 
We assessed the hypervulnerability to sound of patients, using the minimal sound-exposure 2 
eliciting ABRs. ABRs were first recorded in response to 250 impulse stimuli (clicks, with a 3 
repetition rate of 20/s) at 99 dB above the normal detection threshold (the maximum level 4 
with this equipment, a Vivosonic IntegrityTM Version 4.50), 20-30 dB above the ABR 5 
threshold in the tested ear. The averaging was then extended to 500 and 1000 clicks, and 6 
wave identification, amplitudes and latencies post click onset were compared for the three 7 
averaged ABRs. In control patients, averaging was prolonged until about 4000 responses to 8 
clicks had been collected. After a 10-minute pause with no sound stimulus, the procedure 9 
was repeated. TEOAEs were averaged just before the first ABR procedure, then just after, in 10 
response to 260 series of clicks presented at 40 dB above the normal detection threshold 11 
(these clicks were therefore inaudible in patients).  12 
 13 
Recording of mouse vocalizations  14 
The protocol was adapted from that described by Menuet et al. (2011). The mice were 15 
placed in a polyethylene cage covered with a metal wire lid. A free field microphone (type 16 
4192, ½-inch, Brüel & Kjaer) was placed 2 cm above the metal lid, in the center of the cage. 17 
The microphone output was preamplified (microphone power supply type 2801, Brüel & 18 
Kjaer) and digitized by a computer sound card (Dell D830; Dell Inc.) at a sampling rate of 19 
192 kHz. Acoustic vocalizations in the 5-90 kHz frequency range were stored online with 20 
Adobe Audition 1.5 software. They were analyzed with software developed in Matlab (The 21 
MathWorks Inc., MA) providing a spectrographic display of vocalizations in the time-22 
frequency domain, from which the total vocalization time, mean intensity of vocalizations, 23 
and spectral complexity of vocalizations were determined. 24 
 25 
 6 
Housing of mice in an acoustically quiet environment 1 
As most of the noise to which young mice are exposed is due to vocalizations (Ehret & 2 
Riecke, 2002), we split pups from the same litter into three groups, which were then placed 3 
in isolated boxes. The pups were separated before P10, corresponding to several days before 4 
hearing onset in mice. The boxes were kept in quiet booths, shielded from the sounds 5 
emanating from other cages. The cages of the first group contained two mice and a foster 6 
mother, those of the second group contained four mice and a foster mother, and those of the 7 
third group contained the remaining pups (6 to 10) and their mother. 8 
 9 
Quantification of lipid peroxidation 10 
We determined the concentration of malondialdehyde, a by-product of lipid peroxidation, 11 
with the thiobarbituric acid-reactive substances assay kit (Cayman Chemical Company) and 12 
fluorometry at 590 nm. Three independent experiments were performed. For each assay, 13 
cochlear sensory epithelia were microdissected from 30 Pjvk+/+ and 30 Pjvk-/- mice. 14 
 15 
Plasmids and DNA transfection 16 
The full-length pejvakin cDNA was obtained by RT-PCR on a double-stranded cDNA 17 
library prepared from the organs of Corti of P7 C57BL/6 mice. It was inserted into the 18 
pIRES2-EGFP vector (Clontech). The mutant pejvakin clones (missense and frameshift 19 
mutations) were prepared from the wild-type pejvakin clone with the QuikChange™ Site-20 
Directed Mutagenesis kit (Stratagene). HeLa cells were transiently transfected using 21 
Lipofectamine™ 2000 (Invitrogen), according to the manufacturer’s instructions. 22 
 23 
Treatment of mouse embryonic fibroblasts with H2O2 24 
 7 
Fibroblasts were isolated from mouse embryos at embryonic day 13.5 and cultured as 1 
described by Xu (2005). The cells were incubated in DMEM (Gibco) supplemented with 0.1 2 
mM β-mercaptoethanol, and 0.5 mM H2O2 for 4 hours at 37 °C, under normoxic conditions 3 
(95% air). The culture medium was then replaced with H2O2-free medium. Cell viability was 4 
checked 18 hours after H2O2 treatment, by measuring mitochondrial reductase activity with 5 
the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) (Sigma M2128) 6 
assay. A polyclonal antibody against peroxisome membrane protein 70 (PMP70, Abcam 7 
ab3421) was used to label peroxisomes. 8 
 9 
AAV-Pjvk viral constructs and intracochlear viral transduction  10 
AAV2/8-Pjvk-IRES-EGFP was obtained by inserting the murine pejvakin cDNA flanked by 11 
an IRES-EGFP reporter cDNA sequence into the multiple cloning site of the 12 
pENN.AAV.CB7.CI.RBG vector (PennVector P1044, Penn Medicine Vector Core - 13 
University of Pennsylvania School of Medicine). The virus was produced and titrated by 14 
Penn Medicine Vector Core. AAV8-Pjvk was produced by inserting the murine pejvakin 15 
cDNA into a single-promoter Ad.MAX™ shuttle vector (ITR-CAG-Dfnb59-WPRE-PolyA-16 
ITR; SignaGen Laboratories). The virus was packaged and titrated by SignaGen 17 
Laboratories. 18 
Intracochlear viral transduction was carried out as described by Akil et al. (2012). A fixed 19 
volume (2 µl) of a solution containing AAV8-Pjvk or AAV2/8-Pjvk-IRES-EGFP 20 
recombinant viruses (1013 viral genomes/ml) was gently injected into the perilymphatic 21 
compartment of the cochlea through the round window. The pipette was withdrawn, the 22 
round window niche was quickly sealed with fascia and adipose tissue, and the bulla was 23 
sealed with adhesive tape (3M Vetbond).  24 
 25 
 8 
Anti-oxidant treatment 1 
All anti-oxidant drugs were purchased from Sigma. A dose of 1% N-acetyl-cysteine, or a 2 
cocktail of 0.75% α-lipoic acid, 0.5% α-tocopherol and 1% N-acetyl-cysteine, was added to 3 
the drinking water of Pjvk-/- mice during and after pregnancy, such that that the Pjvk-/- pups 4 
received the drug first in utero, and then via breast milk until P21. The auditory function of 5 
the pups, raised in groups of four pups per cage, was tested on P21. 6 
 7 
Immunofluorescence studies 8 
For the detection of lipid oxidation products in the cochlea by immunohistofluorescence, 9 
inner ears were dissected in phosphate-buffered saline (PBS) and fixed by immersion in 4% 10 
paraformaldehyde (PFA) in PBS for 2 hours at 4°C. The samples were decalcified by 11 
incubation in 10% EDTA in PBS, pH 7.4, for 4 days at 4°C, fixed again in 4% PFA in PBS 12 
for 1 hour, rinsed twice in PBS for 10 minutes each, and immersed in 20% sucrose in PBS 13 
for 12 hours. They were embedded in Tissue Freezing Medium (Triangle Biomedical 14 
Sciences) and frozen. Cryostat sections (12 µm thick) were used for 15 
immunohistofluorescence, with an antibody against 4-hydroxy-2-nonenal (1:200, Abcam 16 
ab46545).  17 
For brainstem immunohistofluorescence analyses, P21 mice were killed by the injection of a 18 
lethal dose of ketamine chlorhydrate, and perfused intravascularly with PBS, followed by 19 
4% PFA in PBS. The brain was excised and fixed in 4% PFA in PBS for 1 hour at 4 °C. The 20 
fixed tissues were immersed in 20% sucrose at 4°C overnight, and then frozen in dry ice-21 
cooled isopentane at –30°C to –50°C. Cryostat sections (14 µm thick) were cut and used for 22 
immunohistofluorescence analyses. 23 
For whole-mount immunolabeling analyses, the inner ears were fixed in 4% PFA in PBS, 24 
and the cochlear sensory areas (organ of Corti) were microdissected. The tissues were rinsed 25 
 9 
twice in PBS, then permeabilized and blocked by incubation in PBS containing 20% normal 1 
goat serum and 0.3% Triton X-100 for 1 hour at room temperature. For GFP detection, 2 
whole-mount cochleas were incubated with a mixture of rabbit anti-GFP antibody (1:100, 3 
Invitrogen A11122) and chicken anti-GFP antibody (1:100, Abcam ab13970) in 1% bovine 4 
serum albumin (BSA) in PBS. A monoclonal antibody against parvalbumin (1:500, Sigma 5 
SAB4200545) was used to label auditory neurons. A polyclonal antibody against 6 
peroxisome membrane protein 70 (PMP70, 1:100, Abcam ab3421) was used to label 7 
peroxisomes. Anti-myosin VI (Roux et al., 2009), anti-ribeye/CtBP2 (Santa Cruz sc-5966), 8 
and anti-glutamate receptor 2 (GluR2, Invitrogen 32-0300) antibodies were used to delimit 9 
the contours of IHCs, to label and count IHC ribbons, and to label post-synaptic glutamate 10 
receptors on the dendritic ends of cochlear ganglion neurons, respectively.  11 
For immunocytofluorescence analyses, HeLa and HepG2 cells were fixed by incubation in 12 
4% PFA in PBS for 15 minutes, washed in PBS, and incubated in 50 mM NH4Cl, 0.2% 13 
Triton X-100 solution for 15 minutes at room temperature. The cells were washed and 14 
incubated in 20% normal goat serum in PBS for 1 hour. Cells were incubated with the 15 
primary antibody in 1% BSA in PBS for 1 hour. Peroxisomes were labeled with an antibody 16 
against PMP70 (1:100, Abcam ab3421). An antibody against mitochondrial import receptor 17 
subunit TOMM22 (1:100, Sigma HPA003037) was used to label mitochondria. The mouse 18 
monoclonal antibody against pejvakin (Pjvk-G21) was used at 100 µg/ml to determine the 19 
subcellular distribution of pejvakin. Cells were then washed in PBS and incubated with the 20 
appropriate secondary antibody for 1 hour at room temperature. 21 
For immunofluorescence studies, we used Atto-488- or Atto-647-conjugated goat anti-rabbit 22 
IgG (1:500, Sigma 18772, 40839), Atto-550-conjugated goat anti-mouse IgG (1:500, Sigma 23 
43394) and Alexa-Fluor-488-conjugated goat anti-chicken IgG (1:500, Invitrogen A11039) 24 
as secondary antibodies. Atto-565 phalloidin (1:700, Sigma 94072) and DAPI (1:7500, 25 
 10 
Sigma D9542) were used to label actin and cell nuclei, respectively. Images were acquired 1 
with a Zeiss LSM700 Meta confocal microscope (Carl Zeiss MicroImaging, Inc.). 2 
Peroxisomes were counted automatically with the Particles Analysis plugin of ImageJ 3 
software (Collins, 2007). Enlarged peroxisomes were identified by measurements in two 4 
perpendicular directions, with ImageJ software.  5 
 6 
Morphological analyses and peroxisome staining 7 
For scanning electron microscopy studies, mouse inner ears from P15 and P30 mice were 8 
fixed by perfusion of the perilymphatic compartment with 2.5% phosphate-buffered 9 
glutaraldehyde, and rinsed in PBS. Cochleas were then microdissected, dehydrated in graded 10 
ethanol solutions, and dried to critical point. Processed specimens were then mounted on 11 
aluminum stubs with colloidal silver adhesive and sputter-coated with gold palladium before 12 
imaging in a JSM-6700 F Jeol scanning electron microscope. Inner ears from 10 Pjvk+/+ 13 
mice (three at P15, four at P30, and three at P60), and 12 Pjvk-/- mice (three at P15, five at 14 
P30, and four at P60) were analyzed.  15 
For transmission electron microscopy studies, cochleas were prepared as previously 16 
described (Thelen et al., 2009). They were fixed by incubation in 2.5% glutaraldehyde in 0.1 17 
M Sörensen’s buffer, pH 7.4, for 2 hours at 4°C. After several washes in 0.1 M Sörensen’s 18 
buffer (pH 7.4), the samples were postfixed by incubation at 4°C with 2% osmium tetroxide 19 
in the same buffer for 1 hour. The selective staining of peroxisomes was carried out by a 20 
modified version of a published method (Angermüller & Fahimi, 1981). Briefly, the 21 
cochleas were fixed by incubation in 1% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.2, 22 
at 4°C for 1 hour. After several washes in this buffer, the samples were immersed in 10 mM 23 
3,3’-diaminobenzidine (DAB) and 0.15% H2O2 in 0.05 M Teorell-Stenhagen buffer (57 24 
mM boric acid, 50 mM phosphoric acid, 35 mM citric acid, 345 mM NaOH), pH 10.5, for 25 
 11 
45 minutes at 30°C. After several washes in the same buffer, the samples were postfixed by 1 
incubation with 2% osmium tetroxide in H2O for 1 hour at 4°C. All the cochleas were then 2 
washed in deionized water, dehydrated in graded ethanol solutions, and embedded in Epon 3 
(Epon-812, Electron Microscopy Sciences) for 48 hours at 60°C. 4 
Ultrathin sections (70 nm thick) were obtained with an ultramicrotome (Reichert Ultracut E) 5 
equipped with a diamond knife (Diatome). The sections were mounted on copper grids 6 
coated with collodion. Sections for morphological analysis were contrast-stained with uranyl 7 
acetate and lead citrate, for 15 minutes each. The ultrathin sections were observed under a 8 
JEM-1400 transmission electron microscope (Jeol) at 80 kV and photographed with an 11 9 
MegaPixel bottom-mounted TEM camera system (Quemesa, Olympus). The images were 10 
analyzed with iTEM software (Olympus). The quantitative data were obtained with the same 11 
software. 12 
 13 
Acoustic exposure for the quantification of cochlear transcripts and peroxisomes 14 
Three-week-old C57Bl/6 wild-type mice were used. In the first set of experiments, the 15 
animals were exposed to overstimulation for one hour with bandpass-filtered white noise, 16 
the spectrum of which covered the 5-20 kHz interval with an intensity of 105 dB SPL. Both 17 
transcripts and peroxisomes were quantified. In the second set of experiments, in which only 18 
transcripts were quantified, the mice were subjected to bandpass-filtered white noise with a 19 
spectrum covering the 5-20 kHz interval, but a lower intensity (90 dB SPL), for 1 hour. The 20 
white noise signal was generated with in-house Matlab software (The Mathworks), and was 21 
delivered by an amplifier to a set of four Ultrasonic Vifa speakers (Avisoft Bioacoustics). 22 
The speakers were attached to the tops of four custom-made, cylindrical sound-isolation 23 
chambers (15 cm in radius), in which the mice were enclosed. The noise intensity delivered 24 
by the speakers was calibrated with a BK4812 probe (Bruel & Kjaer) placed centrally on the 25 
 12 
lower surface of the isolation chambers. The sound field within each chamber varied by less 1 
than 10 dB over the lower surface. 2 
 3 
Microarray analysis and quantitative RT-PCR 4 
Total RNA was extracted from dissected organs of Corti from Pjvk-/- and wild-type  (Pjvk+/+) 5 
P15 mice in Trizol reagent (Invitrogen), purified on RNeasy columns (Qiagen), and tested 6 
on an Agilent (Waldbronn) 2100 Bioanalyzer. Three biological replicates were run for each 7 
genotype. The cRNAs obtained from 100 ng of RNA were amplified with the GeneChip 8 
Expression Two-Cycle 3’ amplification system (Affymetrix). Fragmented biotin-labeled 9 
cRNA samples were hybridized to Affymetrix Mouse Gene ST 1.0 arrays. The array was 10 
then washed and stained according to the Affymetrix protocol. The stained array was 11 
scanned at 532 nm with an Affymetrix GeneChip Scanner 3000, producing CEL files. Gene 12 
expression levels were estimated from the CEL file probe-level hybridization intensities 13 
with the model-based Robust Multichip Average algorithm (Bolstad et al. 2003). Arrays 14 
were compared in local pool error tests (Jain et al., 2003), and the p values were adjusted 15 
with the Benjamini–Hochberg algorithm (Benjamini & Hochberg, 1995). The fold 16 
differences reflect the relative expression levels of the genes in the organs of Corti of Pjvk-/- 17 
mice normalized with respect to Pjvk+/+ mice.  18 
The differences in Mpv17, c-Dct, Gpx2, CypA, c-Fos, and Hsp70 transcript levels between 19 
sound-exposed and unexposed cochleas were analyzed by quantitative RT-PCR. For sound-20 
exposed mice, cochleas were collected at 1 hour, 3 hours, 6 hours, and 18 hours after sound-21 
exposure. RNA was extracted from dissected organs of Corti, with the NucleoSpin® RNA II 22 
kit (Macherey-Nagel). Quantitative RT-PCR was performed with the Universal Probe 23 
Library (UPL) system from Roche. UPL probes were labeled with a fluorescein derivative 24 
(FAM), and the fluorescence was read with the Applied Biosystems 7500 Real-Time PCR 25 
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System. The thermocycling conditions were 50°C for 2 minutes, followed by 95°C for 2 1 
minutes, and then 40 cycles of 95°C for 15 s and 60°C for 30 s. Three independent 2 
experiments were performed for each sound-exposed or unexposed cochlea. Each assay was 3 
conducted for the target transcript probe-set in a multiplex reaction in which the 4 
glyceraldehyde-3-phosphate dehydrogenase (Gapdh) probe set was used as an internal 5 
control. Relative levels of target transcripts were determined by the comparative cycle 6 
threshold (CT) method. The relative copy number for each target transcript was calculated as 7 
2−ΔΔCT. The sequences of the primers and UPL probes are available on request. 8 
Transcription levels in the organ of Corti were compared, for each gene, between sound-9 
exposed and unexposed mice, in unpaired Student’s t-tests. 10 
  11 
Measurements of synaptic exocytosis and IK,f (BK) current in IHCs, and non-linear 12 
capacitance in OHCs  13 
Experiments were carried out on explants of the organ of Corti. The dissecting-steps were 14 
performed in a cold (5-10°C) perilymph-like solution containing (in mM): 135 NaCl, 5.8 15 
KCl, 1.3 CaCl2, 0.9 MgCl2, 0.7 NaH2PO4, 5.6 D-glucose 2 Na pyruvate and 10 Na-HEPES; 16 
pH 7.4 and osmolality near 300 mosmol/kg. The freshly dissected sensory organ was then 17 
mounted flat and continuously perfused at room temperature (22-24°C) in a perilymph-like 18 
solution. The sensory hair cells were viewed through a X40 LWD water immersion 19 
objective (NA = 0.8) on an Olympus BX51WI microscope. Whole-cell voltage clamp 20 
recordings were obtained using 3-4 MW  electrodes pulled from borosilicate glass 21 
capillaries (1B150F-4, WPI Sarasota Fl) on a Sachs-Flaming Microelectropuller (Model PC-22 
84, Sutter Instrument Company). Acquisition was done using the Patchmaster	   software 23 
(HEKA). 24 
Ca2+ current and exocytosis recordings in IHCs were performed in the perilymph-like 25 
 14 
solution containing 5 mM Ca2+ and supplemented with 1 µM TTX (Sigma), 10 mM TEA-Cl 1 
and 100 nM apamin (Latoxan). The internal pipette solution contained the following (in 2 
mM): 150 CsCl, 1 MgCl2, 5 TEA-Cl, 1 EGTA, 5 Na2ATP, 0.5 Na2GTP, 5 Cs-HEPES; pH 3 
7.4 and osmolality near 300 mosmol/kg. The liquid junction potential was about 2 mV and 4 
was not corrected in our Cm experiments. Real time changes in membrane capacitance (ΔCm) 5 
were measured using the “track-in” circuitry the HEKA EPC 10 patch clamp amplifier as 6 
previously described (Dulon et al., 2009). A 2.5 kHz sine wave of 15-20 mV was applied to 7 
the cells from a holding potential of –80 mV. Cm signals were low-pass filtered at 80 Hz. 8 
ΔCm responses were measured 50 ms after the end of the depolarizing pulse, and averaged 9 
over a period of 100 to 300 ms. 10 
For BK current measurement in IHCs, IHCs were bathed in the perilymph-like solution. The 11 
internal solution was a 290 mOsm KCl-based internal solution containing (in mM): 135 12 
KCl, 0.1 CaCl2, 1.5 MgCl2-6H2O, 11 EGTA, 5 HEPES, 2.5 Na2ATP; pH 7.4. Series 13 
resistance compensation (50-65%; Rs = 6.34 ± 0.34 MΩ) was applied on line with the series 14 
resistance compensation circuitry of the amplifier throughout recordings. To construct the 15 
current-voltage curves, IK,f current amplitude were measured at 1.3 ms after the start of 16 
voltage-pulse (from a holding potential of -80 mV) and at the end of the depolarization step. 17 
Paxilline, 4-aminopyridine, and XE991, blockers of IK,f, IK,s, and IK,n currents, respectively, 18 
were added to the external solution when necessary. 19 
Nonlinear capacitance measurements were performed as described previously (Beurg et al., 20 
2013).  21 
 22 
Imaging of mitochondrial membrane potential in a hemicochlea preparation 23 
We used the hemicochlea preparation described by Dallos and coworkers (Teudt and 24 
Richter, 2007). Briefly, P17- P30 mice were lightly anaesthetized with isoflurane gas and 25 
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decapitated. The cranium was cut in half along the median sagittal axis. The temporal bones 1 
were removed and fixed to the stage of a vibrating tissue cutter (Vibratome 3000) with 2 
cyanoacrilate glue. Cochleas were then cut in half along the mid modiolar plane with a 3 
microtome blade (R35 Feather, Osaka, Japan) under ice-cold modified perilymph (22.5 mM 4 
NaCl, 120 mM sodium gluconate, 3.5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 10 mM 5 
HEPES, 5.5 mM glucose). The pH was adjusted to 7.3-7.4, and the solution was saturated 6 
with 100 % O2. The upper half of the cochlea was discarded after cutting. Only the lower 7 
parts were used for experiments.  8 
For functional imaging of mitochondrial membrane potential (∆ψm), the hemicochleas were 9 
loaded with 5 µM rhodamine 123 (Rh123, Invitrogen) for 5 minutes at room temperature, 10 
then washed. When Rh123 is used in the quenched mode, mitochondrial depolarization 11 
produces a marked increase in the fluorescence, and ∆ψm changes can be followed reliably 12 
(Nicholls and Ward, 2000; Duchen et al., 2003). A perfusion of the protonophore carbonyl 13 
cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP, Sigma) at a concentration of  (2 µM) 14 
was used to trigger ∆ψm collapse. 15 
Hemicochleas were continuously perfused with modified perilymph in an experimental 16 
chamber. The perfusion velocity was 3.5 ml/minute, and the solution was 100 % saturated 17 
with O2. All experiments were performed at 36 ± 0.5 oC. Fluorescent images were obtained 18 
with an upright epifluorescent microscope (Olympus BX50WI) equipped with a 4x objective 19 
(Olympus XLFluor 4x/340 NA 0.28). With this set up, we were able to image the entire 20 
hemicochlea preparation. Oblique illumination was used for orientation purposes. Changes 21 
in ∆ψm were observed over the whole section of the cochlear ganglion and organ of Corti in 22 
the basal, middle and apical cochlear turns. Rh123 was excited at 495 ± 5 nm with a 23 
monochromator equipped with a xenon arc lamp (Polychrome II; T.I.L.L. Photonics 24 
GMBH). Emitted light was filtered by a 535/50 band-pass filter (Chroma Technology 25 
 16 
Corporation) and detected with a cooled CCD camera (Photometrics Quantix), at an image 1 
frame rate of 12 images/minute. Image intensities were background-corrected using a nearby 2 
area devoid of loaded cells. Axon Imaging Workbench 6 software (Axon Instruments) was 3 
used for image acquisition and detailed offline analysis. The data were further analyzed and 4 
plotted with Wavemetrics Igor Pro 6. The rise time of the evoked mitochondrial 5 
depolarization was determined as the time needed from the start of the response to 6 
maximum intensity. 7 
 8 
SUPPLEMENTAL FIGURE LEGENDS 9 
Figure S1. Strategy for the targeted replacement of the Pjvk wild-type allele with a 10 
floxed allele. (A) Schematic diagram of the murine Pjvk gene and the targeting construct 11 
used to produce a floxed Pjvk allele (Pjvkfl) with loxP sequences (triangles) flanking exon 2, 12 
followed by a PGK-neo cassette. DTA: diphtheria toxin A fragment. An additional SacI site 13 
(in bold) was engineered after the first loxP site, for Southern blot analysis. Small arrows 14 
indicate the positions of the PCR primers used to screen for clones of recombinant 15 
embryonic stem cells. Right panel: Southern blot analysis of SacI-digested genomic DNA 16 
from Pjvk+/+ (+/+) and Pjvkfl/+ (fl/+) mice. Exon 2 of Prkra (a gene flanking Pjvk, on the 17 
centromeric side) was used as the probe for Southern blot analysis. The probe hybridizes to a 18 
4.6 kb fragment from the floxed allele and a 7.2 kb fragment from the wild-type allele. (B) 19 
RT-PCR analysis of the Pjvk transcript in the inner ears of Pjvk+/+ and Pjvk-/- P7 mice. Pjvk-/- 20 
mice were obtained by crossing Pjvkfl/fl mice with transgenic mice carrying the cre 21 
recombinase gene under the control of the ubiquitous PGK promoter. The expected 1059 bp 22 
amplicon was detected in the Pjvk+/+ mouse (lane 1), whereas a 963 bp fragment was 23 
detected in the Pjvk-/- mouse (lane 2), because of the deletion of exon 2. M, DNA size 24 
marker: ϕX174 DNA HaeIII digest. 25 
 17 
 1 
Figure S2. Transduction of neurons in the auditory pathway and of cochlear hair cells 2 
with the AAV8 and AAV2/8 viral vectors, respectively. AAV8-EGFP or AAV2/8-EGFP 3 
was injected into the cochleas of P3 mice, and transduced cells were detected at P21 by 4 
EGFP immunostaining (green) on cryosections of the cochlear ganglion (basal turn) (A, 5 
lower panel) and of the cochlear nucleus (A, upper panel), and whole-mount preparations of 6 
the organ of Corti from the cochlear middle turn (B). The block diagram shows the organ of 7 
Corti and the main ascending auditory pathway that projects both ipsilaterally and 8 
contralaterally (for the sake of clarity, we show projections from only one cochlea). AAV8-9 
EGFP-transduced auditory neurons are identified by their parvalbumin (red) and EGFP 10 
(green) co-immunoreactivity (A). AAV2/8-EGFP transduces the vast majority of inner hair 11 
cells (IHCs) and a smaller proportion of outer hair cells (OHCs). The numbers on the DAPI-12 
stained cell nuclei indicate the three rows of OHCs (B). Scale bars are 50 µm in (A) and 10 13 
µm in (B). 14 
 15 
Figure S3. (A) Progressive degeneration of the organ of Corti in Pjvk-/- mice. Upper 16 
panels: Scanning electron micrographs showing surface views of the organ of Corti in the 17 
basal turn of the cochlea from P60 Pjvk+/+ and Pjvk-/- mice. In the Pjvk-/- mouse, many outer 18 
hair cells (OHCs), inner hair cells (IHCs), and pillar cells (PCs) are missing. Scale bars are 5 19 
µm. Lower panels: Light micrographs of cross sections taken from the middle turn of the 20 
cochlea in Pjvk+/+ and Pjvk-/- mice at P90. In the Pjvk-/- mouse, all OHCs, IHCs, and 21 
supporting cells have degenerated and the organ of Corti is collapsed (arrow). In addition, 22 
the numbers of nerve fibers and cochlear ganglion neurons (arrowheads) are markedly 23 
decreased. Scale bars are 80 µm. (B) Increased lipid peroxidation in the cochlea of Pjvk-/- 24 
mice. Cryosections of the organ of Corti (middle turn, upper panels) and of the cochlear 25 
 18 
ganglion (apical and basal turns, lower panels) from P60 Pjvk+/+ and Pjvk-/- mice, 1 
immunolabeled for 4-HNE, a by-product of lipid peroxidation (green), and stained with 2 
DAPI (blue) to show cell nuclei. Asterisks indicate the nuclei of OHCs and IHCs. In the 3 
Pjvk-/- mouse, some OHCs and cochlear ganglion neurons are missing, but the OHCs present 4 
are highly immunoreactive for 4-HNE (arrows), as are the cochlear ganglion neurons, 5 
especially in the basal turn. Scale bars are 20 µm. 6 
 7 
Figure S4. (A) Quantitative RT-PCR in Pjvk-/- mice to confirm microarray results for 8 
the genes involved in redox balance. "Fold change" denotes the level of expression of the 9 
gene in the organ of Corti of Pjvk-/- mice relative to that in Pjvk+/+ mice, with the minus sign 10 
indicating downregulation. All four genes tested, c-Dct, Mpv17, CypA, and Gpx2, were less 11 
strongly expressed in the organ of Corti of P15 Pjvk-/- mice than in Pjvk+/+ mice, in both 12 
microarray (transcriptome) and quantitative RT-PCR (qRT-PCR) analyses. (B) Effect of 13 
exposure of wild-type (Pjvk+/+) mice to loud sound on the expression of Pjvk and other 14 
anti-oxidant genes in the organ of Corti. Relative levels (fold change) of Pjvk, c-Dct, 15 
CypA, c-Fos, and HSP70 transcripts, as measured by quantitative RT-PCR in the organ of 16 
Corti of sound-exposed (5-20 kHz, 90 dB for 1 hour) P21 wild-type (Pjvk+/+) mice after 6 17 
hours in a silent environment versus levels in unexposed mice. Sound-exposure leads to a 18 
marked increase in the levels of Pjvk and CypA transcripts (3.0 ± 0.3-fold and 4.0 ± 1.0-fold, 19 
respectively), but only a moderate (less than 2-fold) increase in the levels of c-Dct, Hsp70, 20 
and c-Fos transcripts. This indicates that Pjvk and CypA are involved in the early cochlear 21 
response to noise. Error bars indicate the SEM.  22 
Figure S5. (A) Pejvakin is associated with peroxisomes in transfected HeLa cells. 23 
Transfected HeLa cells producing pejvakin (Pjvk-EGFP, upper panel) and untransfected 24 
cells (lower panel) were immunostained with both an anti-pejvakin antibody (Pjvk-G21) and 25 
 19 
an antibody against peroxisome membrane protein 70 (PMP70). Cell nuclei were stained 1 
with DAPI (blue). Colocalization of the immunostainings of pejvakin (red) and PMP70 2 
(green) was observed in transfected cells (see inset for higher magnification of the boxed 3 
area). Pejvakin was not detected in untransfected cells. (B) Absence of immunolabeling in 4 
inner hair cells (IHCs) from P21 Pjvk-/- and Pjvkfl/fl Myo15-cre+/- mice with the Pjvk-5 
G21 antibody demonstrates the specificity of this antibody (see Figure 5B for 6 
immunolabeling in Pjvk+/+ IHCs). (C) Pejvakin immunostaining of dividing peroxisomes. 7 
Double immunolabeling of HepG2 cells for pejvakin (red) and PMP70 (green). Upper panel: 8 
arrowheads indicate pejvakin-immunoreactive protrusions from pre-existing peroxisomes. 9 
Lower panel: boxed areas show pejvakin-immunoreactive string-of-beads structures 10 
corresponding to elongated and constricted peroxisomes (preceding final fission) are boxed. 11 
Scale bar is 10 µm in (A), 5 µm in (B), and 2 µm in (C). 12 
 13 
Figure S6. (A) Proliferation of peroxisomes induced by H2O2 in Pjvk+/+ mouse 14 
embryonic fibroblasts. F-actin (red), PMP70 (green), and DAPI (blue) staining of Pjvk+/+ 15 
(left panel) and Pjvk-/- (right panel) mouse embryonic fibroblasts (MEFs), treated with 0.5 16 
mM H2O2 for 4 hours or left untreated, and analyzed 18 hours later. H2O2-treatment 17 
increases the number of peroxisomes only in the Pjvk+/+ cells (see quantification in Figure 18 
5C). (B) Larger numbers and enlargement of peroxisomes in transfected HeLa cells 19 
producing wild-type and mutant forms of pejvakin, respectively. In untransfected cells 20 
(NT) and in cells producing EGFP alone, EGFP and wild-type pejvakin (Pjvk), or EGFP and 21 
the p.T54I, p.R183W, p.C343S, or p.V330Lfs*7 mutated forms of pejvakin, peroxisomes 22 
were identified on the basis of their PMP70-immunoreactivity. The upper panel shows F-23 
actin (red), DAPI (dark blue), EGFP (green), and PMP70 (light blue) staining, whereas the 24 
lower panel shows only the PMP70 immunostaining of individual cells delimited by a white 25 
 20 
border. The number of peroxisomes is larger in cells producing wild-type pejvakin, and 1 
smaller in the cells producing any of the mutated forms of pejvakin, than in cells producing 2 
EGFP alone (see quantification in Figure 5D). In addition, cells producing the mutated 3 
forms of pejvakin contain enlarged peroxisomes (arrowheads, and see insets for 4 
magnification; see also quantification in Figure 5D). Scale bar is 20 µm in (A) and 10 µm in 5 
(B). 6 
 7 
Figure S7. (A) Normal number of ribbon synapses and Ca2+-dependent synaptic 8 
exocytosis in Pjvk-/- inner hair cells (IHCs). Upper panel : The synapses between IHCs and 9 
the primary auditory neurons were double-immunolabeled for the presynaptic marker ribeye 10 
that labels IHC ribbons (green), and the postsynaptic glutamate receptor GluR2 (red). The 11 
bar chart shows the quantitative analysis of ribbon synapses from Pjvk+/+ (blue) and Pjvk-/- 12 
(red) mice on P20.  N: cell nucleus of IHCs. Lower panel: Synaptic function. Left: Bar chart 13 
representation of the peak of ICa and of the increase in membrane capacitance (ΔCm) in 14 
response to a 100 ms voltage step from -80 mV to -10 mV in Pjvk+/+ (blue) and Pjvk-/- (red) 15 
P20 IHCs. ICa and ΔCm values were similar in Pjvk-/- IHCs (126 ± 16 pA and 21.3 ± 2.2 fF, n 16 
= 6) and Pjvk+/+ IHCs (110 ± 16 pA and 20.0 ± 2.0 fF, n = 5; t-test, p = 0.47 and p = 0.64). 17 
Middle: Synaptic transfer function describing the relation between ΔCm and ICa in Pjvk+/+ (n 18 
= 3; blue dots) and Pjvk-/- (n = 3; red dots) P20 IHCs. Cells were stimulated by a constant 19 
100 ms voltage step at various membrane potentials from -80 mV to -5 mV.  Fits to single 20 
data points were done by using a simple power function with N = 0.70 ± 0.10 and N = 0.63 ± 21 
0.10 in Pjvk-/- and Pjvk+/+ IHCs, respectively. The mean slope representing Ca2+ efficiency 22 
was 0.17 ± 0.05 and 0.15 ± 0.02 fF/pA in Pjvk-/- IHCs and Pjvk+/+ IHCs, respectively (t-test, 23 
p = 0.73). Right: Increase in membrane capacitance (ΔCm) produced by a train of 20 24 
successive 100 ms voltage steps from -80 to -10 mV, separated by 100 ms time intervals, in 25 
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Pjvk+/+ (n = 3; blue dots) and Pjvk-/- (n = 3; red dots) P20 IHCs. Pjvk-/- and Pjvk+/+ IHCs 1 
display similar linear increase in membrane capacitance (mean slope of 5.14 ± 0.10 and 5.04 2 
± 0.35 fF/stimulus in Pjvk-/- and Pjvk+/+ mice, respectively; t-test, p = 0.76). 3 
(B) Most Pjvk-/- inner hair cells (IHCs) lack the fast voltage-activated IK,f current. IK,f, 4 
IK,s, and IK,n are the main K+ currents found in mature IHCs. Upper left: Example traces for 5 
potassium currents (IK,f + IK,s) recorded for a voltage step to -10 mV from a holding potential 6 
of -80 mV, in a P19 Pjvk+/+ (blue) and two P19 Pjvk-/- (red) IHCs. Enlarged time scale of the 7 
current onset, on the right, shows the fast voltage-activated outward current, IK,f, in the 8 
control IHC and one Pjvk-/- IHC, whereas in the other Pjvk-/- IHC, only a slow current can be 9 
observed. Upper middle: Current-voltage (I-V) curves representing mean amplitudes of IK,f  10 
(measured 1.3 ms after the onset of the depolarizing pulse, a time point at which IK,s is not 11 
yet activated) and of the steady-state current (IK,f + IK,s, measured at the end of the voltage 12 
step) as a function of the membrane potential (Vm). For Pjvk-/- IHCs, two cell groups were 13 
defined, based on the presence (open circles) or absence (closed circles) of IK,f. Upper right: 14 
bar charts showing the mean amplitudes of the IK,f and IK,f + IK,s currents obtained in 15 
response to a voltage-step from -80 to -10 mV. IK,f was detected in all 7 IHCs from Pjvk+/+ 16 
mice, but in only four of the 11 IHCs from Pjvk-/- mice. The current-voltage relationship at 17 
1.3 ms did not display significantly different conductances in Pjvk+/+ IHCs (160 ± 20 nS, n = 18 
7) and in the few Pjvk-/- IHCs showing IK,f (129 ± 25 nS, n = 4 out of 11), with a mean IK,f 19 
amplitude at -10 mV of 1.2 ± 0.2 nA and 0.9 ± 0.3 nA, respectively (p = 0.53 for both 20 
conductance and amplitude comparisons). Lower left: IK,f blockade with paxilline (10 µM), a 21 
selective BK channel blocker, in Pjvk+/+ and Pjvk-/- IHCs submitted to a voltage step from -22 
80 to -10 mV. No current reduction in the presence of paxilline (both at 1.3 ms and steady 23 
state plateau) was observed in the Pjvk-/- IHCs that displayed only the slow outward current 24 
component IK,s, indicating that these cells indeed do not have functional BK channels. The 25 
 22 
amplitudes of IK,s were similar in Pjvk+/+ and Pjvk-/- IHCs (1.76 ± 0.41 nA vs. 1.65 ± 0.24 1 
nA at -10 mV; t-test,  p = 0.6). Lower middle: Traces representing potassium currents (IK,f + 2 
IK,s + IK,n) in an IHC from a P19 Pjvk-/- mouse. Lower right: Bar chart showing the mean 3 
amplitudes of IK,n measured at -120 mV in  IHCs from P19 Pjvk-/- and Pjvk+/+ mice. Inward 4 
IK,n currents, sensitive to XE991 (2 µM; data not shown), were recorded in all P19-P24 5 
Pjvk+/+ and Pjvk-/- IHCs in response to hyperpolarizing voltage steps from -80 mV to -120 6 
mV, and their amplitudes were similar in the two groups (0.93 ± 0.13 nA vs. 1.3 ± 0.28 nA, 7 
respectively; n = 6 in both groups; t-test, p = 0.3). Together, these results indicate that Pjvk-/- 8 
IHCs display normal IK,s and IK,n currents, but most of the cells (64 % of the Pjvk-/- IHCs 9 
tested) lack the IK,f (BK) current. 10 
(C) Impaired electromotility of Pjvk-/- OHCs. Left panel: Non-linear capacitance (Cnon-11 
linear) of 10 Pjvk+/+ and 16 Pjvk-/- OHCs, as a function of the membrane potential (Vm). 12 
Smooth lines are fits based on a two-state Boltzmann function (implemented in JClamp) 13 
with values of Qmax, V1/2, z, and Clinear of: 1.1 ± 0.9 pC, -33.6 ± 3.5 mV, 0.75 ± 0.05, and 6.6 14 
± 0.2 pF for Pjvk+/+ OHCs, and 0.83 ± 0.37 pC, -30.5 ± 1.3 mV, 0.85 ± 0.03, 7 ± 0.3 pF for 15 
Pjvk-/- OHCs. Right panel: Bar charts showing a 30% decrease of maximal charge density in 16 
Pjvk-/- OHCs. 17 
 (D) Dissipation of the ∆ψm revealed no difference in mitochondrial status between 18 
Pjvk+/+ and Pjvk-/- cochleas. Functional imaging of ∆ψm was performed over sections of 19 
the organ of Corti and cochlear ganglion, in turns of the hemicochlea of P17-P30 mice, 20 
after loading the preparation by Rh123. A perfusion of the protonophore FCCP was used to 21 
trigger ∆ψm collapse. The starting latencies (SL) of the response and rise times (RT) of the 22 
evoked depolarization peaks were calculated and compared. The inset graphs demonstrate 23 
the way of determination of SL and RT on a representative trace. In the bar charts, basal, 24 
middle, and apical denote cochlear turns. The six regions of interest are delimited by black 25 
 23 
borderson the insets showing the fluorescent and obliquely illuminated images of a 1 
hemicochlea. Error bars represent SEM (n = 12 ears for each genotype). n.s., not 2 
significant, *** p < 0.001. 3 
 24 
Table S1. Transcriptional changes in the organ of Corti of Pjvk-/- mice 
 
 
Gene (encoded protein) 
Accession  
number 
Fold 
change 
Adjusted 
p-value 
Probe set  References 
Genes involved in ROS metabolism      
Mpv17 (Mpv17, mitochondrial inner membrane protein)  NM_008622 -3.40 3.34E-22 10529091  Binder et al, 1999; Meyer zum Gottesberge, 2001; 
Spinazzola et al., 2006 
c-Dct (c-Dopachrome tautomerase) NM_010024 -3.28 9.95E-50 10422249 Michard et al., 2008a; Michard et al., 2008b 
CypA (Cyclophilin A) NM_008907 -2.15 1.78E-09 10545337 Lee et al., 2001; Ge et al., 2009 
Gpx2 (Glutathione peroxidase 2) NM_030677 -1.59 4.87E-11 10401109 Evans and Halliwell, 1999 
Genes with modified expression in tumors      
Tax1bp3 (Tax1 (human T-cell leukemia virus type I) binding protein 3) NM_029564 -2.88 2.16E-15 10378334 Kanamori et al., 2003 
Plunc (Palate, lung, and nasal epithelium associated protein) NM_011126 2.20 6.89E-10 10477475 Bingle et al., 2005; He et al., 2005; Benlloch et al., 
2009 
Cd59a (CD59a antigen) NM_001111060 -2.13 1.78E-30 10474229 Madjd et al., 2003; Watson et al., 2006 
Pramel3 (Preferentially expressed antigen in melanoma-like 3) NM_031390 -1.94 6.05E-04 10601790 Schenk et al., 2007 
Lrp1b (Low density lipoprotein-related protein 1b) NM_053011 1.82 3.21E-07 10482336 Sonoda et al., 2004; Nakagawa et al., 2006; Lu et al., 
2010 
Genes encoding putative cell growth inhibitors      
Ifi44 (Interferon-induced protein 44) NM_133871 -2.20 3.45E-12 10502791 Hallen et al., 2007;  Kim et al., 2009 
Ifit3 (Interferon-induced protein with tetratricopeptide repeats 3) NM_010501 -2.08 2.72E-10 10462618 
Ifit1 (Interferon-induced protein with tetratricopeptide repeats 1) NM_008331 -1.75 1.53E-07 10462623 
Ifitm3 (Interferon induced transmembrane protein 3) NM_025378 -1.60 1.42E-11 10569017 
 25 
Genes encoding ribosomal proteins      
Rps13 (Ribosomal protein S13) NM_026533 2.04 5.61E-08 10565434 Wool, 1996; Lai and Xu, 2007 
Rps23 (Ribosomal protein S23) NM_024175 -1.92 1.06E-08 10491730  
Rpl36 (Ribosomal protein L36) BC086914 -1.74 2.57E-04 10394609  
Gene involved in ubiquitin proteolytic pathway      
UbB (Ubiquitin B) NM_011664 -1.64 2.93E-07 10376864 Fischer et al., 2003; de Pril et al., 2010 
Gene encoding a synaptic protein      
a39-Takusan (Alpha39-takusan) EF651836 2.30 1.39E-07 10417411 Tu et al., 2007 
Fold change reflects the expression level of the gene in the organ of Corti of Pjvk-/- relative to Pjvk+/+ mice. + and - denote up-regulation and down-regulation, respectively. The p values  
were adjusted using the Benjamini-Hochberg algorithm. 
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